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Mushrooms were recorded for their medicinal values in ancient Chinese medicinal 
medicas. In recent research, it is found that polysaccharides from fruit bodies have 
significant antitumor effect, however, only little report has been made on the antitumor 
effect of mushroom sclerotia. Mushroom sclerotia have a richer source of 
polysaccharides when compared with fruit bodies. The specific aim of this study was 
to use different extraction methodologies to isolate the active polysaccharides from three 
sclerotia, namely, Pleurotus tuber-regium (PT), Poria cocos (PC) and Polyporus 
rhinocerus (PR). Both in vitro and in vivo experiments were carried out to identify and 
compare their antitumor and immunomodulatory properties. 
Firstly, polysaccharides of three sclerotia were extracted by hot water alone and 
expressed as PT-W，PC-W and PR-W. In addition, a sequential extraction scheme by 
solubilising the polysaccharides using sonication in alkaline medium, followed by hot 
water，cold alkali and hot alkali extraction was carried out to fractionate the sclerotial 
polysaccharides. Among all the extracts, the yield of the sonication fraction from both 
PR and PC was the highest (>70% dry weight). To improve the solubility of the alkali 
fractions, carboxymethylation (CM) was carried out to modify their chemical structures 
by the introduction of anionic groups. Results showed that all the native and CM 
fractions from the sclerotia contained glucose (>80%) as the predominant sugar as 
determined by gas chromatography. The hot water extracts of PT and PR had a very 
high protein content of more than 40%. 
vitro antiproliferative activity of the mushroom sclerotial fractions were 
evaluated using different cancer cell lines by the trypan blue exclusion assay. Hot 
water extracts of the three sclerotia showed significant antiproliferative effects (>40%) 
towards human acute promyelocytic leukemic cells (HL-60) (/?<0.05), with PR-W 
having an inhibitory effect >90% (^<0.05) at 400 |ig/ml. No antiproliferative effect of 
breast cancer cells (MCF-7) was observed on all fractions tested except the CM-PT 
fractions. None of the fractions had cytotoxic effect on the growth of normal monkey 
kidney cells (VERO). 
PR-W was found to be the most potent extract among all three sclerotia, and it was 
further tested for its dose-response relationship against HL-60 and human chronic 




100昭/ml and 300^g/inl, respectively. PR-W could almost completely prevent the 
growth of murine sarcoma S-I80 cells (>90% at lOOjug/ml) but had no antiproliferative 
effects against the hepatocellular carcinoma cells (HepG2). It was revealed by flow 
cytometry that the cell cycle of HL-60 was significantly (p<0.05) arrested at the Gj 
phase after 24 hours incubation with PR-W (at 200 jig/ml). 
All fractions from PR administered by intraperitoneal injection to BALB/c mice at 
20mg/kg body weight showed significant inhibition (/7<0.05) on Sarcoma S-180 tumor 
growth in the animal. No significant inhibition on tumor growth could be found by the 
use of various fractions of PT and PC at a similar dose. However, the sonication 
fraction of PR and PR-W showed a significant inhibition of tumor growth (about 80%) 
0<O.OOI), with tumor regression observed in the mice treated with PR-W. 
Immunomodulating effects of PR-W were further investigated using normal 
BALB/c mice. It was found that levels of various kinds of cytokines in the serum of 
mice treated with PR-W (at doses of 5 mg/kg and 50 mg/kg body weight) were higher 
than the controls with the level of interleukin-13 being the highest. Number of 
peritoneal exudate cells (PEC) and splenocytes in mice treated with PR-W were higher 
and the weight of spleen was significantly heavier than the control (^<0.05). 
From the above chemical and biological evaluation, it is very likely that the 
polysaccharide-protein complexes present in PR-W fractions were mainly responsible 
for the potent in vitro and in vivo antitumour effect of PR as well as the 
immunomodulating effects. It is anticipated that PR-W may be developed into 














菌核乾重量的 7 0 % �單用熱水從虎奶兹和虎乳靈芝筚取出的多糖蕴含多於 4 0 % 
的蛋白質，因此推斷它們屬於多糖蛋白質複合物。 
人體急性白血病細胞（H L - 6 0 )是其中一種用作體外活性實驗的細胞。所有 
由相繼萃取熱水方法提取出的菌核多糖（P T - W，P C - W和P R - W )對急性白血病 
細胞具有高於4 0 %的抑制作用’其中虎乳靈芝的多糖 ( P R - W )在4 0 0 / z g / m l的濃 
度下，能將急性白血病細胞的生長降低達9 0 %以上。在所有提取出來的菌核多 
糖中，只有C M - P T對人體乳腺癌細胞（M C F - 7 )有抑制效果。此外，所有提取 
出來的菌核多糖都顯示出對正常猴賢細胞 (Vero)沒有毒性。 
用熱水從虎乳靈芝提取的多糖 ( P R - W )能夠在1 0 0 / / g / m l的濃度下’有效地 
將急性白血病細胞的生長減低一半。同時，這種多糖在 3 0 0 / z g / m l的濃度下’ 
能有效將K 5 6 2細胞的生長減慢一半和在 i o o # g / m I的漠度下’擁有高於 9 0 %抑 
制實體瘤（Sarcoma 180)生長的作用。但這多糖卻欠缺對人體肝癌細胞（HepG2) 
的抑制佢作用。從流動細胞儀檢測虎乳靈芝的水溶性多糖 ( P R - W )在體外環境下 
對急性白血病細胞 ( H L - 6 0 )週期，發現虎乳靈芝的水溶性多糖與急性白血病細 
胞培養 2 4 小時後’細胞的增殖開始在 G i 階段被間斷。 
所有由虎奶兹及获茶提取的多糖，均未能有效地阻止植入雄性小白鼠體内 
的實體瘤生長。相反地，以超聲波和熱水抽取的虎乳靈芝多糖 ( P R _ w )，則有效 
地降低腫瘤的生長達 8 0 %以上。其中在注射熱水抽取的虎乳靈芝多糖 ( P R _ w ) 
後’實體瘤在雄性小白鼠體内，有完全消失的情况。 
鑑於虎乳靈芝的水溶性多糖具有較佳的體外及體内抗癌活性’因此對它作 
出進一步的免疫力活性測試。P R - W被注射入小氣腹腔後’小鼠的血清被抽出， 
發現P R - W對白細胞介素 - 1 3 ( i n t e r l u e k i n - 1 3 )的增加明顯地較對照組為高。與此 
同時，注射 P R - W 小鼠的腹腔細胞和脾喊細胞數目在注射 P R - W 後有明顯增 
長’小氣脾職的重量亦在注射後，相較對照組，有顯著增加。 
從以上生物和化學的分析’虎乳靈芝的多糖蛋白質複合物是具有提高體 
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Chapter 1. Introduction 
1.1 Introduction on growth cycle of mushroom 
The developmental stages in the mushroom life cycle vary according to 
different genus of mushrooms and different environmental conditions. Spores are 
first released and allowed to germinate to a filamentous structure called hyphae. 
Hyphae continue to extend and upon they meet, they fuse and reproduce mitotically 
so that the genetic materials can be combined. This resulting of mated mycelium 
grows much faster then the unmated one from single spores. This kind of mating 
facilitates the growth diversity of mushroom that gives rise to a significant 
competition among mushroom to adapt to the same ecological niche. When the 
mycelium expands, it gradually forms a web of cells called mycelial network. In 
addition, the thickening of mycelial mat will occur when side branches of mycelium 
arise (Stamets and Chilton, 1983; Stamets, 1993). 
In responding to sudden environmental stimuli, for example, a different 
humidity and intensity of light provided, mycelium becomes triggered to form 
fruiting bodies. This kind of shift of stage is known as "biological switch". The 
whole mass of mycelium begins to arrange in a homogeneous way, increase in 
density and aggregate to form young primordia. By the time primordia are formed, 
they may rest for a period and upon a suitable environment, they mature rapidly. 
The internal walls and septae begin to form and individual cells expand that result in 
an explosive generation of various mushroom tissues (fruitbody). At this stage, the 
fruitbody of most mushroom species enlarge to differentiate into cap, stem, veil and 
gills. The cap has a protective function of the spore-producing gills. Basidia 
A 
‘ 1 
emerge as spore-producing cells with club-shaped sterigmata projecting upwards. 
Each tip of the sterigmata will gradually swell to form a small globular cavity, which 
will eventually become a spore. They are evenly dispersed on the gills and more 
basidia form as the mushrooms emerge (Stamets and Chilton, 1983; Stamets, 1993). 
During unfavorable conditions, for example, winter or drought weather, 
sclerotia will be formed. Sclerotia are made up of fungal mass of hyphae that 
resemble a hardened tuber, wood-like texture. When the mushrooms form sclerotia, 
they enter resting phase in the life cycle and remain dormant. Once the conditions 
become favorable again, the sclerotia will germinate and mushroom fruitbody will 
emerge. Formation of sclerotia allows the mushroom to survive through inclement 
weather and is one of the important stages in the life cycle (Stamets, 1993). 
声 j I 
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Figure 1.1 The Mushroom Life Cycle (adapted from Stamets, 1993) 
2 
1.2 Literature review of mushroom biological activities 
1.2.1 Various bioactivities of mushroom 
There are many kinds of biological activities mediated by mushrooms due to 
the presence of various types of chemical components. These include 
hypocholesterolemic, antiviral, antibacterial, antiparasitic, antidiabetic, 
hepatoprotective and antitumor effects. They act on the host either through a 
non-immune origin or immunomodulatory route (Wasser and Weis, 1999). i 
1.2.2 Components responsible for various bioactivities of mushrooms 
Low-molecular-weight substances in the mushrooms are mostly responsible for 
hypocholesterolemic effects. Both lovastatin (Endo, 1988) and eritadenine (Chibata 
et al., 1969) were well known for their cholesterol lowering effect. Lovastatin 
j 
could be found in mushrooms, especially mycelium belonged to the genus Pleurotus 
and it acted as a competitive inhibitor of HMG CoA reductase, which was a key ‘ 
enzyme in cholesterol metabolism (Endo, 1988). Eritadenine could be isolated 
from fruit body of Lentinus edodes (Shiitake mushroom) and had the function of 
accelerating excretion of ingested cholesterol and its metabolites instead of inhibiting 
the biosynthesis of cholesterol (Mizuno et al., 1995a, b). Polysaccharides isolated 
from Tremella fuciformis was shown to have the ability to delay the agglutination of 
blood platelets (prolong of thrombotic formation), lower blood viscosity and thus 
reduce LDL-cholesterol level in rats (Nakajima et al., 1989). In addition to these 
isolated compounds, extracts from Grifola frondosa (Adachi et al., 1988) and 
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cholesterol-lowering effects by reducing blood pressure in rats. 
Polysaccharides extracted from various kinds of mushrooms showed 
pronounced effects in combating different viruses, bacteria and parasites. One of 
the well-known polysaccharides, lentinan, extracted from Lentinus edodes, was 
found to be most effective against tumor growth as shown in the Table 1 • 1 (Mizuno 
et al.，1995a, b; Hobbs, 1995; Wasser and Weis, 1999). Another famous 
polysaccharide, schizophyllan extracted from Schizophyllum commune was proven to 
have inhibitory effects on many bacteria commonly infectious to humans like 
Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Klebsiella 
pneumoniae (Chang and But, 1986). 
Patients suffering from hepatitis or other liver damages could be healed 
effectively by the adoption of mushroom polysaccharides. Lentinan extracted from 
Lentinus edodes had the ability to promote the antibodies against hepatitis B and 
improve liver function (Lin and Huang, 1987; Mizoguchi et al., 1987; Amagase, 
1987; Mizuno, 1995a, b). 
1.3 Mushroom polysaccharides and polysaccharide-protein complexes 
1.3.1 Polysaccharides important for antitumor effects 
Among different biological activities brought about by various kinds of 
mushroom components, the antitumor activities of mushroom polysaccharides have 
drawn the most attention in recent years. It is very common for cancer patients to 
consume mushroom extracts for treatment in China and Japan. 
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In "Ben Cao Gang Mu", Ri-Ji-Chin already reported the efficacies of 
Ganoderma lucidum (Fr.) Karst (LingZhi) in 1552. In 1968, it was first mentioned . 
that the hot water extract from the fruit body of some edible fungi from Polyporaceae 
family, had a remarkable host-mediated antitumor activity against Sarcoma, S-180 
(Ikekawa et al.，1968). Since then, scientists are interested in investigating the 
antitumor substances in mushrooms. 
There are various kinds of macromolecules accounted for the antitumor activities ^ 
.. I 
of mushrooms, including heteropolysaccharides, peptidoglycan, proteoglycan, chitin, 
lectin, RNA and polysaccharides (Mizuno et al., 1995a). Among all, 
polysaccharides from different species of mushrooms showed pronounced effects of 
in vivo antitumor activities as shown in Table 1.1. The major component in these ‘ 
active polysaccharides was identified as p-D-glucan, in which it could only produce 
D-glucose with acid hydrolysis (Mizuno et a l , 1995a). 
As mentioned before, other components in mushrooms like 
) 
i 
heteropolysaccharides were also responsible for their antitumor activities. 
Heteropolysaccharides referred to those P-D-glucans with side chains of other 
monosaccharides, for example, mannose and galactose. 
P-D-glucan，the principal antitumor polysaccharides have a right-handed triple 
helical structure as shown by NMR analysis and x-ray diffraction (Marchessault et al., 
1977). The well-known chemical structure of this P-D-glucan has been shown to be 
a (l-^6)-P-D-glucosyl branched (1—3)-p-D-glucopyran，possessing specific rotation 




1.3.2 Polysaccharide-protein complexes important for antitumor effects 
Most medicinal mushrooms are extracted with hot water to give an active 
component that is chemically not a pure glycan. Protein residues are often bound 
with glycans to form glycoproteins like peptidoglycans and proteoglycans or even 
complexes. There are two main types of these complexes, p o l y s a c c h a r i d e - p r o t e i n 
complex (PSPC) and protein-bound polysaccharide (PSK, Krestin). The major 
difference between these two compounds is that there are rhamnose and arabinose 
found in PSPC and fticose in PSK (Tzianabos, 2000). The backbone of PSPC is not 
a glucan, but rather a heteroglycan-protein. Its protein portion predominantly 
consists of aspartic acid, glutamic acid and serine (Liu et al., 1995). On the other 
hand, PSK is a protein-bound p-glucan (Tsukagoshi et al., 1984; Kobayashi et al., 
1995) that refers especially to the protein-bound polysaccharides extracted from 
Coholus versicolor. PSK has drawn greater research interest than PSPC due to its 
renowned antitumor activities. 
With the presence of protein, total sugar content in PSK would be relatively 
l ower and g lucose wou ld no longer be the sole monosacchar ide . A l though glucose 
is still the major component, other monosaccharides such as marmose, fucose, xylose 
and galactose might also be present as a mixture (Tsukagoshi et al., 1984). The 
main polysaccharidic portion of PSK is P-glucan that has a l ->3 backbone with 
branches of, 1 — 4 and 1 — 6 bonds as shown by gas c h r o m a t o g r a p h y - m a s s 
spectrometry (GC-MS) (Hirase et al., 1976). For the protein portion, PSK consists 
mainly of acidic amino acids such as aspartic acid, neutral amino acids like valine 
and basic amino acids as lysine. Together with the polysaccharidic portion, PSK 
consisted of both protein and polysaccharides that have a better water solubility and 
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an average molecular weight of 9.4 x lO^ (Tsukagoshi et al., 1984). 
1.4 Structure- function relationship of antitumor activities of polysaccharides 
Not all p-D-glucans have similar antitumor effects because different parameters 
would influence the activities. This was due to the reason that antitumor activities 
of p-D-glucan would be affected by solubility in water, molecular weight, degree of 
branching and different kinds of side branches linked to the main chain (Mizuno et 
al., 1995a). 
1.4.1 Effect of molecular mass 
A wide range of polysaccharides with different molecular masses can be 
isolated during extractions. This difference in molecular weight would cause 
diverse immunomodulatory effects. It is generally found that those polysaccharides 
with high molecular weight would exert greater antitumor effects and 
immunomodulatory activities (Adachi et al., 1990a, b; Kim et al., 1990). This is 
particularly noticeable in the case of Grifola frondosa in which there was a change of 
biological activities with respect to fractions of different molecular weights (Adachi 
et al•，1990a). On the other hand, both high- and low-molecular-weight fractions 
obtained from lentinan and shcizophyllan had similar effects against Sarcoma, S-180 
(Sasaki and Takasuka, 1976; Tabata et al., 1981; Ogawa and Kaburagi, 1982). 
Therefore, it would be difficult to have a definite conclusion about the influence of 
molecular masses. 
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1.4.2 Effect of linkages 
Heterogenous polysaccharides having various kinds of glycosidic linkages can 
be obtained as a mixture when being extracted. In mushrooms, main chains of 
glucans with p-l，3-linkages having p-l,6-linkages as branches are most responsible 
for antitumor activities. In general, p-glucans with more 1,6-linkages would have less 
antitumor activities (Franz, 1989). However, it is in conclusive to relate a specific 
type of glucan linkage for an effective antitumor activity as the structure of glucan 
could vary greatly in different mushroom species. 
1.4.3 Effect of degree of branching 
Apart from the linkages of the main chain and side branches, degree of 
branching greatly contributed on the immunotherapeutic effects of polysaccharides. 
Degree of branching refers to the ratio of occurrence of branches to the main chain 
unit (Yadomae and Ohno, 1996). A balance should be striked for degree of 
branching so that the resulting glucans would not be just linear or with too many 
branches. It has been suggested that if the branching ratio of p-glucans were less 
than 1/2 (branch-to-main-chain unit), the antitumor activity would become more 
significant than that with more branching (Ohno et al.’ 1995). 
Mushroom glucans with potent antitumor activities are largely linear 
macromolecules that could exert a remarkable effect both in vitro and in vivo. 
Poria cocos is one of the well-known examples showing the antitumor effects of 
modified glucan. Native p-glucan extracted from Poria cocos is a highly branched 
pachyman lost its antitumor effects when branches were removed by Smith 
A 
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degradation to form pachymaran that has a linear structure (Chihara et al.，1970a). 
On the contrary, the highly branched glucan called OL-2 with a branching ratio of 
2/3 extracted from Omphalia lapidescens showed pronounced antitumor activity 
against Sarcoma, S-180 (Saito et al.，1992). OL-2 was also found to be effective to 
stimulate the expression of various kinds of cytokine genes like IL-la and IL-ip 
(Nemoto et al., 1993; 1994). 
1.4.4 Effect of conformation 
There are at least three types of secondary structures identified for /5 glucans, 
including triple helix, single helix and random coil (Mizuno et al., 1995a). In 
particular, the conformation of (1 一 3)-p-glucans would be different due to the 
various physical properties resulting from different extraction or isolation methods. 
The (l—3)-p-glucans with high molecular weight would exist as single and/or triple 
helix. The single helix glucan is not stabilized in aqueous media and it would adopt 
a random coil conformation. This is because in aqueous media like hot water and 
aqueous alkaline solution, the (l->3)-p-glucan having low molecular weight is only 
stabilized in a random coil conformation (Yadomae and Ohno, 1996). On the other 
hand, the branched (l->3)-P-glucans has mainly a triple-helix conformation in 
aqueous solution, while the linear (l->3)-p-glucans of intermediate chain length 
would have a random coil conformation in aqueous solution (Mizuno et al., 1995a). 
The conformation of glucans is one of the factors for the explanation of antitumor 
activities of bioactive polysaccharides (Yadomae and Ohno, 1996). 
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1.5 Immunomodulatory effects of mushroom polysaccharides and 
polysaccharide-protein complexes 
1.5.1 Immunomodulatory effects of polysaccharides 
In general, polysaccharides would not exert a direct cytotoxic effect on cancer 
cells and instead, it would enhance a host-mediated immunomodulatory response by 
activating the immune system to fight against cancer (Wasser and Weis, 1999). 
Polysaccharides could stimulate the activities of various immune cells like 
macrophages, NK cells, T cells and B cells and in turn, enhance the release of a wide � 
range of cytokines involved in different antitumor mechanisms. 
1.5.1.1 Bioactive polysaccharides in Lentinus edodes 
Lentinan, a hot water extract of Lentinus edodes, is a well-known 1 
immunomodulator which induces in vitro tumor necrosis factor-a (TNF-a) : 
production by macrophages (Abel et al., 1989). The structure of lentinan has been 
shown to be a triple helical p-(l—3)-glucan branched with P-(l—6)-glucose residues 
that is free of protein (Aoki, 1984; Hobbs, 2000). Activity of NK cells was 
stimulated when lentinan was administered in vivo to the host that helped 
suppressing tumor growth (Miyakoshi and Aoki, 1984). Cytotoxicity of peritoneal 
macrophages was enhanced by lentinan against metastatic tumor cells in mice 
(Ladanyi et al., 1993) and lentinan could increase the production of cytotoxic 
T-lymphocytes (CTL), macrophages and induction of other nonspecific immune j 
t 
i 
responses (Wasser and Weis, 1999). The release of cytokines stimulated by lentinan | 




et a l , 1999). 
1.5.1.2 Bioactive polysaccharides in Ganoderma lucidum 
In both China and Japan, Ganoderma lucidum has long been used for treating 
various kinds of diseases during ancient times up until now and is known as 
"mushroom of immortality" (Shiao et al., 1994). The major bioactive component in 
this mushroom was polysaccharides, especially P-D-glucan, that activate many , 
effector cells such as macrophages, NK cells and T cells (Zhou and Gao, 2002). In 
particular, water extract from G. lucidum has been shown to be effective in 
stimulating T cells to release cytokines like IL-lp, IFN-y, TNF-a, IL-2，IL-6 which 
are proven to be effective in combating tumor cells (Wang et al., 1997; Mao et al., 
1999). One of the water-soluble polysaccharides isolated from G. lucidum could :! 
augment splenic NK cells cytotoxicity in tumor-bearing mice (Lee et al., 1995). 
Induction of apoptosis in HL-60 and U937 was observed ex vivo due to the increment 
of macrophage responses in producing more cytokines, nitric oxide and other 
mediators that in turn initiated the release of interleukins (Lee et al., 1995; Wang et 
al., 1997). 
1.5.2 Immunomodulatory effects of polysaccharide-protein complexes 
PSPC and PSK are potent immunomodulators in enhancing the bioactivities of 
killer T cells, NK cells and macrophages (Rowan et al., 2003). PSPC could 
enhance humoral immunity no matter in normal or tumor-bearing mice and induce 
the antibody production in mice. Such antibody induction is even more significant 
on tumor-bearing mice (Zhou, 1988). On the other hand, PSK seems to be effective 
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on stimulating immune responses only on hosts with tumor but not on those under 
normal conditions (Tsukagoshi et al., 1984). 
1.5.2.1 Bioactive polysaccharide-protein complexes in Trametes versicolor 
Both PSPC and PSK can be isolated from T. versicolor which both serve as 
immunostimulators specific to T-cells and antigen-presenting cells (APC) such as 
macrophages (Tzianabos, 2000). It was found that human T cells were more 
sensitive than murine ones to the stimulus by PSPC (Li, 1999). PSPC from T. 
versicolor is effective in inducing T-helper cells (CD4+) and thus increase the ratio of 
T-helper cell/T-suppressor cells (CD8+) (Liang and Wang, 1996). In addition, 
PSPC has augmentation in macrophage response so that more IL-1，IL-6 and IFN can 
be released (Zhou, 1988). In contrast, PSK from T versicolor could only restore a 
host immune response after supressed by tumor (Tsukagoshi et al., 1984; Dong et al., 
1996，1997). It has been reported that PSK would enhance the gene expression of 
cytokines like TNF-a, IL-1, IL-8 and IL-6 secreted by macrophages (Kato et al., 
1995; Liu et al” 1996a，b). These cytokines act by stimulating cytotoxic T cells to 
fight directly against tumors and B lymphocytes would be induced to produce more 
antibodies. In particular, TNF-a induced by PSK played a major role in its 
antitumor effects (Kato et al., 1995). The key role of this mushroom in having 
antitumor effect seems to be a combined effect of PSPC and PSK in stimulating a 
number of different immune cells. 
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1.5.3 Immunotherapeutic effects of mushroom polysaccharides 
After discussing about the antitumor effects of various kinds of 
polysaccharides, it is obvious that polysaccharides are effective in stimulating the 
host immune system by acting as biological response modifiers (BRMs). This gives 
rise to an alternative approach to treat cancer in addition to the traditional surgery, 
chemotherapy and radiotherapy that may bring more side effects to the patients after 
treatment. BRMs should cause no harm or additional tension to the host and should 
be able to help the body relieving environmental and psychological stresses. Most 
importantly, they should also act nonspecifically to the host major and immune 
systems (Berkhman, 1980). 
1.6 Cell cycle and apoptosis 
It has long been a practice to test for the in vitro antiproliferative effects of 
polysaccharides on various cell lines as a preliminary way to assess their biological 
activities. Nowadays, it is common to evaluate the antiproliferative activity of a 
novel agent by using cell cycle arrest as a target to observe the control of apoptosis 
that is closely related to the occurrence of malignancies (Senderowicz, 2004). 
1.6.1 Introduction of cell cycle 
There are four phases, namely Gi，S, G2 and M phase, in a cell cycle and each 
phase is controlled by a particular checkpoint (Fig. 1.2) (Damia and Broggini, 2004). 
Gi (gap 1) phase is the first phase of a cell cycle responsible for the onset of DNA 
replication. During the late G\ phase, if there is adequate stimulus for proliferation, 
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the cell can pass this restriction point to enter the S phase (Planas-Silva and 
Weinberg, 1997). S phase is the one accountable for the synthesis of DNA. The S 
phase checkpoint will not permanently arrest a cell, but instead, it will delay the 
DNA synthesis process to allow time for active repair of DNA damage (Bartek and 
Lukas, 2001; Rhind and Russell, 2000). G2 (gap2) phase is the time gap between 
the end of DNA replication and mitosis. The G2 checkpoint allows the progression 
to mitosis if DNA damage is being repaired (O'Connell, Walworth and Carr, 2000). 丨 
M phase is the mitotic phase that cell begins to divide in the course of prophase, ； 
metaphase, anaphase and telophase. There is a checkpoint just before the exit of | 
j 
this phase to make sure that the cell only divides with completed chromosome 
separation (Amon, 1999; Rudner and Murray, 1996). Only if the cell can pass | 
I 
I 
through a particular checkpoint that it can proceed to the next phase to complete the | 
cell cycle. If a cell encounters an unfavorable condition or the DNA damage is not ； 
I 
i 
repairable, it will enter a dormant phase called Go when it is being arrested at Gi I 
j 
phase. During this phase, some of the genes like p21 will express to inhibit cyclins 丨 
necessary for cell cycle progression in order to allow time for DNA repair (Potten 
and Wilson, 2004). 
1.6.2 Cell cycle regulation 
j 
Cell cycle is tightly regulated by means of "cell cycle checkpoints" (Paulovich 
et al., 1997) so that repair mechanisms are allowed to take place. When there are 
defects in the cell cycle that cannot be repaired, the apoptotic pathway is activated. 
Apoptosis refers to a programmed cell death that induces morphological changes on 
cells including DNA fragmentation, membrane ruffling, cell shrinkage and formation 
of apoptotic bodies. Cell membranes will remain intact without the leakage of cell | 
VH i 
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content so that no inflammatory responses would be triggered (Reed, 2002; Potten 
and Wilson, 2004). Apoptosis may be regarded as a self-checking process so that 
mistakes occur in DNA synthesis cannot be passed to the progenies of damaged cells. 
Cells that escape these controls will have abnormal proliferation and may give rise to 
tumors (Senderowicz, 2004). 
The actual substances involved in controlling the cell cycle include cyclins and 
they are molecules that would form complexes with cyclin-dependent kinases (CDKs) 
or the proteins expressed by different cell division cycle genes. Their expression is 
strongly related to the occurrence of apoptosis as well (Freeman et a l , 1994). 
Cyclin D is the most widely studied one among Gi cyclins in controlling Gi 
checkpoint as it is involved in helping the cell out from Go phase back to G\ phase 
(Sherr，1994). Cyclin-dependent kinase 4 forms complexes with cyclin D (cdk4-D) 
and this forms another complex with proteins like p21 and Rb. As the Gi phase 
comes to the end, cyclin E is induced to form complexes with cdk2 so that it can be 
transferred to S phase for DNA replication. However, this complex is soon 
degraded to release cdk2 and form another complex with cyclin A that is important 
for DNA synthesis. When this DNA synthesis is completed, cyclin A forms another 
complex with cdkl, also known as cell division cycle 2(cdc2) so that the cell can 
pass this phase to Gj phase (Grana and Reddy, 1995; Potten and Wilson, 2004). 
When coming to G2 phase, cdc2 now forms complex with cyclin B in which this 
complex is important, and yet, unstable and breaks down easily (Grana and Reddy, 
1995). In this way, the cell cycle is being regulated. 
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1.6.3 Antitumor effects through apoptotic gene regulation 
Due to the better understanding of regulation of cell cycle and mechanism of 
apoptosis，they have become new targets for antitumor research. Protein products 
of genes responsible for controlling the occurrence of apoptosis include p53, Bcl-2, 
Bax, p21 and Rb. 
p53 is the well-known tumor suppressor gene and is known as the "guardian of 
genome" (Potten and Wilson, 2004). It can induce both Gi and Gj arrest, but play a 
more crucial one in the former one. p53 can upregulate the expression of 
proapoptotic genes coding for p21, mdm2, gadd45 and Bax (Fortin et al., 2001; 
Miyashita and Reed, 1995; Moroni et al., 2001) and at the same time, can 
downregulate the expression of antiapoptotic genes coding for IL-6, Rb and Bcl-2 
(Potten and Wilson, 2004). Therefore, p53 is the main therapeutic target in 
antitumor research in which expression of p53 will be elevated for apoptosis to take 
place; this is a useful finding so that the p53 gene in tumor cells should be 
reactivated for them to have apoptosis and stop the proliferation of tumors (Vousden 
and Lu, 2002). 
Bcl-2 is the gene product of B-cell lymphoma 2 gene, {bcl-2) which has the 
molecular weight of 25-26 kDa and is the first survival death genes to be recognized 
(Potten and Wilson, 2004). It is usually found overexpressed in many tumors (Cory 
and Adams, 2002) as cancer cells may cause the cell to produce its own Bcl-2 
proteins to allow the cell becoming more resistant to apoptosis so that the cancer cell 
can continue to proliferate. Thus, oligonucleotides become the new target against 
the Bcl-2 proteins (Tock et al., 2003). On the other hand, Bax (Bcl-2-associated X 
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protein) is the protein antagonistic to Bcl-2 and it serves as a proapoptotic molecule. 
It would bind to Bcl-2 proteins to form homodimers or heterodimers to strike for a 
balance for the determination of cell death to occur or not. If apoptosis is to be 
taken place, Bax-Bcl-2 will become a proapototic molecule helping to release 
apoptosis-inducing factors from mitochondria (Potten and Wilson, 2004). 
p2l gene is one of the most popular /?Ji-related genes and its gene product, 
p21，inhibits the phosphorylation and thus the activation of cyclin-dependent kinases 
so that cell cycle progression is hindered. This results in cell cycle arrest and both 
cyclin E and cyclin A are mostly affected by p21 (Potten and Wilson, 2004). 
Retinoblastoma protein, Rb, is an important protein acting on Gi/S transition in 
cell cycle (Weinberg, 1995). When Rb protein is inactivated, it suppresses E2F 
transcription factors and inhibits the cell cycle to progress. However, when it is 
activated by mitogenic factor, it is phosphorylated and released from E2F, resulting 
in the deactivation of E2F-target genes for S phase entry (Harbour and Dean, 2000; 
Liu and Greene, 2001). This is because E2F transcriptional factors are important in 
regulating cell cycle as they are necessary for induction of cell cycle progression 
factors like cyclins and cyclin-dependent kinases. The E2F factors also play an 
essential role in apoptosis since they regulate expression of proapoptotic genes 
including apaf-1 (DeGregori, 2002). Together with E2F factors, Rb expression is 
important for apoptosis to take place. 
18 
^ y ^ Protease pulse 
Entry blocked by SPF ^ ^ ^ ^ 丄 degrades cyclins 
Mitoses promoting Z 




Destruction of cyclins Cyclm E 
S phase promoting factor (SPF) 
Entry blocked by MPF 
Cyclin E-CDK2 complex Cyclin B1, B2-cdc2* 
Gq degraded in S (p21, PCNA) (unstable in M) 
V Cyclin D X 1 I 1 
I ~ I ^ 1 1 1 ~ I 
START ^ — — i 1 
Transition or restriction point Cyclin A-CDK2 complex 
Committment to replicate DNA ，PCNA) 
十 (also linked with apoptosis) 
Cyclins D1, D2, D3 and cyclin dependent kinases (CDK's) 
CDK4/6-D forms complexes (short T1/2) with essential proteins 
which are phosphorylated and activate essential substrates for DNA synthesis 
Complexes with PCNA, p21, Rb etc. 
* cclc2 (CDK1) cell division cycle gene (mitosis promoting factor MPF) 
Figure 1.2 The Cell Cycle (adapted from Potten and Wilson, 2004) 
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1.7 Mushroom sclerotium with antitumor activity 
1.7.1 Literature review on Pleurotus tuber-regium 
Pleurotus tuber-regium (PT), commonly found in Africa, is a kind of mushroom 
that is both edible and medicinal. It is not only used as a food substitute, but also 
used as a kind of medicine in treating headache, stomachache, fever and colds (Oso, 
1977; Akobundu and Eluchie, 1992). The fruiting body of PT is rich in protein 
(Kadiri and Fasidi, 1990) while its sclerotium is rich in fiber, especially, non-starch 
polysaccharides (Cheung and Lee, 1998). In particular, the bioactive P-glucan 
could be found in large amount (more than 60% dry weight) (Cheung and Lee, 
2000). 
Polysaccharides were extracted with hot water and ultrasonication from PT 
sclerotia (Zhang et a l , 2004c). The hot water extract of PT showed a significant 
inhibition ratio of 55.3% of SI80 solid tumor grown on BALB/c mice, while the 
sonication fraction showed a 30% inhibition but without any statistical significance 
when compared with the control (Zhang et al., 2004c). Hot water extraction 
seemed to be a better method in extracting anti-tumor polysaccharides from PT 
sclerotia. 
In extracting polysaccharides from PT, conditions like high temperature and 
alkaline are used in order to obtain a better yield. Native polysaccharides, 
particularly hot alkali (extracted by autoclaving at 121°0 extracts obtained from PT 
were found to be effective in inhibiting Sarcoma, S-180 in BALB/c mice (45-76% 
tumor size inhibition). For in vitro assays, hot alkali fractions from PT with higher 
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molecular weight (5.8-42.2 x 10"^ ) were found to have better inhibition of 
proliferation of human acute leukemia (HL-60) and human hepatocellular carcinoma 
(HepG2) than those with lower molecular weight (1.0-2.2 x 10"^ ) (Zhang et al., 2001). 
Native p-glucan-rich polysaccharides of PT extracted by hot alkali were 
water-insoluble (Zhang et al., 2001). In order to enhance the water solubility, these 
polysaccharides from PT were chemically modified by substituting the hydroxyl 
groups with different ionic groups, such as sulfate (Zhang et a l , 2004a) and 
carboxymethyl groups (Zhang et al., 2004b). One of the sulfated-hot alkali 
fractions from PT showed an effective anti-viral activity against herpes simplex virus 
type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) as revealed by the 
cytopathic effect assay (CPE) (Zhang et al., 2004a). 
On the other hand, carboxymethylated hot alkali fractions from PT were found 
to have significant in vivo inhibition of Sarcoma, S-180 on BALB/c mice and 
enhanced in vitro inhibition of HL-60 when compared to native ones (Zhang et al., 
2004b). When lipopolysaccharides (LPS) was not injected into mice implanted 
with SI80, there was no significant increase in the plasma TNF-a of mice treated 
with carboxymethylated hot alkali fractions (Zhang et al., 2004b). However, when 
LPS was injected, TNF-a production was significantly induced by more than 2-fold. 
This suggested that the anti-tumor activity of the p-glucan in PT was mediated by 
TNF-a production under the influence of LPS. 
；i 
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1.7.2 Literature review on Poria cocos 
Poria cocos (PC) is one of the most well known traditional Chinese medicinal 
mushrooms. It is also known as hoelen or Fu ling and the sclerotium can be 
collected throughout the year. Its sclerotium can be in the shape of spherical, oval 
or irregular size with a diameter of 10-30 cm. PC is a subterranean fungus, which 
grows together with the roots of various conifers, especially Chinese red pine, 
Taiwan pine and oaks (Liu and Bau, 1980). 
As a traditional Chinese medicine, PC is considered to be with a mild 
sweetness and bland. It is claimed to be effective in treating edema and clear febrile 
illnesses. Different portions of PC have different medicinal uses in which its cortex 
is used as a diuretic and a decoction for cough, while the internal white portion is 
responsible for relieving uneasiness arising from pregnancy and the heat discomfort 
(Hobbs, 1995). In particular, the polysaccharides of PC such as the highly branched 
pachyman and debranched pachymaran have long been proven to exhibit strong 
antitumor and immunomodulatory activities. However, pachyman had relatively 
lower antitumor activity than pachymaran which was debranched by Smith 
degradation (Chihara, 1970a). On the other hand, the low-molecular weight 
tetracyclic triterpenes are also claimed to have immunostimulating and antiviral 
activities (Hobbs, 1995). 
> 
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1.7.3 Literature review on Polyporus rhinocerus 
Polyporus rhinocerus (PR) belongs to the Polyporacea family. The mycelium 
of PR was inoculated and cultivated on potato dextrose agar (PDA) plate with a 
yellowish-brown appearance. After three to five months of growing in an incubator, 
primodia and even sclerotia appeared. PR is a traditional Chinese medicine in 
which there has been some preliminary data showing their effectiveness in treating 
liver cancer, chronic hepatitis and gastric ulcer (Huang, 1999). However, there is 
very little in-depth scientific research data in supporting their biological functions. 
1.8 Objectives 
Mushrooms have been found to be responsible for enhancing various biological 
activities and among all; the antitumor effect has drawn much attention with very 
promising results. It is still not clear about the actual mechanisms of how the active 
ingredients of mushrooms, including polysaccharides and polysaccharide-protein 
complexes to act on the host through an immunostimulatory pathway to fight against 
tumors. Recent researches in cell cycle arrest and apoptosis might provide a better 
means to study different antitumor mechanisms of mushroom. The three sclerotia 
above (section 1.7) mentioned are the research targets in this project. The studies 
on antitumor mechanisms on two lesser-known edible sclerotia, Pleurotus 
tuber-regium (edible) and Poria cocos (edible) together with Polyporus rhinocerus 
(medicinal), would be carried out in order to have a better understanding on the 
target substances responsible for this biological activity. 
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All the mushroom sclerotia were extracted by different solvents to give different 
fractions of polysaccharides and polysaccharide-protein complexes. The influence 
of extraction method on the antitumor activities of these different fractions was then 
studied. These fractions were analyzed chemically to identify their monosaccharide 
profile, total sugar, protein and uronic acid contents. In addition, structural analyses 
were carrying out by chromatographic method including HPLC and GC-MS. All 
these physio-chemical analyses facilitated the identification and structural 
elucidation of the active components in the mushroom sclerotial fractions that were 
accountable for antitumor activities. 
In assessing the antitumor activities of the mushroom sclerotial fractions，both 
in vitro and in vivo assays were carried out. Subsequently, investigations on the cell 
cycle of cancer cell lines and the immunostimulatory effects on mice were carried 
out for studying the mechanisms of the antitumor effect of the mushrrom 
polysaccharides and polysaccharide-protein complexes. 
Finally, relationship of how the structure of the mushroom sclerotial fractions 
affected their biological functions (antitumor activity) was proposed. 
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Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Mushroom sclerotia 
Sclerotia of Pleurotus tuber-regium (Fries) Singer and Polyporus rhinocerus 
Cooke were supplied by the Sanming Mycological Institute in Fujian, China, while 
Poria cocos (Schw.) Ryv. Et Gilbn was purchased from local traditional Chinese 
medicine store (Fig. 2.1). The sclerotia were peeled and milled into powder by a 
meachanical grinder (MFIO, IKA) through a 0.5 mm sieve. 
2.1.2 Animal Model 
Male BALB/c mice were inbred by the Laboratory Animal Services Center 
(LASEC) of the Chinese University of Hong Kong and only 7-8 weeks old mice 
were used for all the experiments. Ten mice were housed in the same cage with free 
access of water and rodent chow. 
> 
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^ H Pleurotus tuber-regium (Fr.) S i n g .(虎奶链）H 
(a) Pleurotus tuber-regium (Fr.) Sing [PT](虎奶薛） 
^ ^ ^ M'olf,poria cocos (Scliw.) Ryv. cl C.ilbn., 
\Ponu cocos (Schw.) Wolf| {{k^) V ；/^  
afe^gfefev-丨权：•::.....々 二 d m 
(b) Poria cocos (Schw.)Ryv. Et Gilbn [PC](获茶） 
Polyporus rhhwcenis (虎乳爷芝） 
(c) Polyporus rhinocerus [PR](虎乳靈芝） 
Fig. 2.1 The sclerotia of (a) Pleurotus tuber-regium, (b) Poria cocos and (c) 
Polyporus rhinocerus 
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2.1.3 Cell lines 
Suspension cell lines including human acute promyelocytic leukemia cells, 
HL-60 (CCL-240, ATCC; American Type Culture Collection), chronic myelogenous 
leukemia cells, K562 (CCL-243, ATCC) and murine sarcoma 180, S-180 (TIB-66， 
ATCC) were grown in 25cm^ tissue culture flask (Sarstedt, Cat. # 83.1810.502) in 10 
ml o f R P M I 1640 medium (Sigma Cat. # R-6540) and Dulbecco's Modified Eagle's 
Medium，DMEM (GIBCO, Cat. # 12100-046). Both media were supplemented 
with 10% fetal bovine serum (FBS) (GIBCO, Cat. # 26140-079), 1% 
penicillin-streptomycin (GIBCO, Cat. # P0781) and 0.1% flingizome (GIBCO, Cat. # 
15290-018). 
Adherent cell lines including human breast adenocarcinoma cells, MCF-7 
(HTB-22, ATCC), human hepatocellular carcinoma cells, HepG2 (HB-8065, ATCC) 
and monkey normal kidney cells, VERO (CCL-81, ATCC) were grown in monolayer 
in 25cm^ tissue culture flask (Sarstedt, Cat. # 83.1810.002) in 6 ml o f R P M I 1640 
medium supplemented with 10 % FBS, 1% penicillin-streptomycin and 0.1% 
flingizome. During subculture, the medium was first discarded and washed with 
phosphate buffered saline (PBS) (8.182 g/L of sodium chloride, 0.201 g/L of 
potassium chloride, 0.204 g/L of potassium dihydrogen phosphate and 1.150 g/L of 
disodium hydrogen phosphate) to remove traces of serum that contained trypsin 
inhibitor. Then, 2 ml of trypsin-EDTA (1.25 ml of 2% EDTA and 5 ml of 2.5 % 
trypsin solution made up with 100 ml sterile PBS) were added to detach the cells 
until they were well dispersed, followed by the addition of 5 ml of completed 
medium before centrifugation at 1000 rpm for 5 minutes. Cell pellets were 
resuspended in fresh medium and cell suspension was transferred to new culture 
27 
flasks. 
All of the above cell cultures were seeded at a concentration of 1x10^ to 1x10^ 
cells/ml and incubated at 37°C in a humidified atmosphere of 5% of CO2. The 
cultures were maintained with replacement of fresh medium at 48-hour interval 
during subculture. 
2.2 Methods 
2.2.1 Extraction Scheme for mushroom sclerotia 
2.2.1.1 Hot water extraction only 
About 20 grams of each mushroom sclerotium were used for a single hot water 
extraction at 95-100�C for 2 hours with a sample-to-solvent ratio of 1:25 (w/v). 
After cooling down the mixture, the mixture was centrifuged at 10000 rpm for 30 
minutes to isolate the supernatant. The whole extraction process was repeated twice 
so that three hot water extracts were obtained. The supematants were pooled and 
ultrafiltrated until the total dissolved solute (TDS) was below 10. The crude hot 
water extracts were lyophilized for later use. 
2.2.1.2 Sequential extraction scheme 
About 20 grams of powdered sclerotia were extracted sequentially with 
sonication, hot water, cold and hot alkali as shown in Figure 2.2. The sample was 
first swollen in IM sodium hydroxide for 48 hours in a sample-to-solvent ratio of 
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1:25 (w/v). This mixture was then transferred into a beaker and neutralized with 
hydrochloric acid. A sonication probe (Sonics, VCX600) together with a 
mechanical stirrer was placed inside the beaker surrounded with an ice bath and 
sonication was carried out for 30 minutes. The mixture was centrifuged at 10000 
rpm for 30 minutes and the supernatant was collected, dialyzed and lyophilized to 
give a sample designated as SON. The residue was washed with distilled water and 
centrifuged at 5000 rpm for 30 minutes for three times to remove salts. After 
washing, the residue was extracted with hot water at 95-100°C for 2 hours. After 
cooling down, the mixture was centrifuged at 10000 rpm for 30 minutes to obtain the 
supernatant. This process was repeated twice to obtain a total of three hot water 
fractions. All the hot water extracts were dialyzed and lyophilized to give a sample 
designated as HWE. The residue was then extracted with 4M sodium hydroxide for 
2 hours in an ice bath with continuous stirring. The mixture was centrifuged at 
10000 rpm for 30 minutes to obtain the supernatant. This cold alkali extraction was 
repeated once and the supernatant were first pooled, neutralized, dialyzed, 
lyophilized and designated as CAE. Lastly, the residue was extracted with 4M 
sodium hydroxide at 95-100°C for 2 hours. After cooling down, the mixture was 
centrifuged at 10000 rpm for 30 minutes to obtain the supernatant. This extraction 
was repeated once and the supernatant were pooled, neutralized, dialyzed and 
lyophilized to give the HAE sample and the final residue (RES) was lyophilized. 
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Sclerotium (about 20g) 
nJ/ Swelling in IM NaOH, l g / 2 5 ml, 48 h 
Sonication, 30 min in ice bath 
Centrifuge at 10000 rpm x 30 min 
Residues Supernatant 
Extraction in boiling distilled water Dialyzed and lyophilized |SON 
( l g / 2 5 ml, 2 hours) for 3 times 
Centriflige at 10000 rpm x 30 min 
Supernatant Residues 
Dialyzed and Extraction in 4M NaOH twice 
lyophilized (1 g/25 ml, 2 hours, 0-4°C) 
HWE| \ i Centrifuge at 10000 rpm x 30 min 
Supernatant Residues 
Neutralized, dialyzed Extraction in 4M NaOH twice 
and lyophilized (lg/25 ml, 2 hours, 95-100°C) 
CAE| \i Centrifuge at 1 OOOOg x 30 min 
Supernatant Residues 
Neutralized, dialyzed (washed and lyophilized) 
and lyophilized RES 
HAE 
Figure 2.2 Sequential extraction scheme of mushroom sclerotia 
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2.2.2 Measurement of monosaccharide profile 
2.2.2.1 Acid Depolymerisation 
About 15 mg of sample was hydrolyzed with 0.7 ml of 12 M concentrated 
sulphuric acid at 35°C for 60 minutes with continuous stirring. The mixture was 
diluted to 2 M sulphuric acid by addition of 3.5 ml distilled water, and the mixture 
was heated in a boiling water bath for 60 minutes. The hydrolysate was cooled to 
room temperature. 
2.2.2.2 Neutral Sugar Derivatization 
Three militers of hydrolysate was transferred to a new test tube and internal 
standard allose (1ml, 1 mg/ml; Fluka，Cat. # 05750) was added. The pH of the 
hydrolysate was adjusted to alkaline by addition of 12 M ammonia. Five 
microliters of octan-l-ol (Sigma, Cat. # 0-4500) and freshly prepared sodium boron 
hydride (0.2 ml, 200 mg/ml in 2 M ammonia; Sigma, Cat. # S-9125) were added to 
reduce the hydrolysate. The mixture was kept at 40°C for 30 minutes. After that, 
0.4 ml of glacial acetic acid was added and vortex-mixed. An aliquot of the mixture 
(0.2 ml) was transferred to a new test tube. Then, 0.3 ml of 1-methylimidazole 
(Sigma, Cat. # 336092) as catalyst and 2.0 ml of acetic anhydride was added to 
acetylate the mixture. The mixture was vortex-mixed and left at room temperature 
for 10 minutes. Five milliliters of distilled water was then added, the mixture was 
vortex-mixed and cooled under tap water to room temperature. One milliliter of 
dichloromethane was added and the mixture was vortex-mixed and stood for 10 
minutes for phase separation. After the upper phase was removed, the lower phase 
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was washed twice with 1 ml of water. The lower phase was dried with anhydrous 
sodium sulphate and then stored in a vial at -20°C before GC analysis. 
2.2.2.3 Gas Chromatography (GC) 
The alditol acetates derivatives of the neutral sugars were quantified by gas 
chromatograph (Hewlett-Packard 6890，USA) using an Alltech DB-225 capillary 
column (15 m x 0.25 mm i.d., 0.25 |_im film) and oven temperature program of initial 
temperature 170�C，followed by a temperature rise of 2°C/min to 220°C with a final 
hold of 10 minutes. The injector and detector were at 270°C. The carrier gas was 
helium and detection was by flame ionization. Individual sugars were corrected for 
losses during hydrolysis and derivatization, and for the response to the flame 
ionization detector. Monosaccharide calibration was made with fucose, rhamnose, 
ribose, arabinose, xylose, mannose, galactose, glucose, glucosamine and 
galactosamine. The N-acetylglucosamine was detected as glucosamine because the 
N-acetyl group at C-2 would be deacetylated by the sulphuric acid hydrolysis (Pazur, 
1994). The values for monosaccharides were expressed as polysaccharide residues 
(anhydro-sugars) by multiplying the amounts of pentoses with a factor of 0.88， 
hexoses with a factor of 0.90 and deoxypentoses with a factor of 0.89. 
The amount of the monosaccharides was calculated as below: 
Amount of individual Peak area monosaccharide in sample x Amount of allose (mg) 
monosaccharide (mg) Peak area aiiose in sample 
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After determining the amount of different monosaccharides, their corresponding 
percentages by weight in the sample were calculated as follows. 
Monosaccharide (Rf x coefficient x dilution factor) x Amount of monosaccharide (mg) x 100% 
% by weight Sample weight (mg) 
Rf - response factor determined from monosaccharide standard 
The relative amount (normalized) of monosaccharide as % of total 
monosaccharide in the sample was calculated as follows. 
o/o of individual monosaccharide x 100% 
Normalized monosaccharide % = 
Total % monosaccharide in the sample 
2.2.3 High Pressure Liquid Chromatography (HPLC) 
2.2.3.1 Size exclusion chromatography 
Size exclusion columns including TSK gel G3000 PW (30 cm x 7.5 mm i.d., 
Supelco, Cat. # 8-05762) with PWH Guard column (7.5 cm x 7.5 mm i.d., Supelco, 
Cat. # 8-06762) and TSK gel G5000 PW (30 cm x 7.5 mm i.d., Supelco, Cat. # 
8-05764) were used for determine the molecular weight profile of mushroom extracts 
according to the profile given by a range of pullulan standards. The solvents used 
were distilled water and 0.2M of sodium chloride solution and the flow rate was set 
at 0.5 ml/min and 3.0 ml/min. Temperature of the column was controlled externally 
at 30°C and each sample or standard was allowed to run for 30 minutes. Signals 
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from each sample or standard were detected by an ultraviolet (UV) detector at the 
absorbance of 280nm and a refractive index (RI) detector connected in series. 
2.2.3.2 Anion exchange chromatography 
BioSuite™ DEAE 10|am Anion Exchange Column (AXC) (75 mm x 7.5 mm 
i.d.，Waters, Cat. # 186002180) was used to separate the mushroom extracts based on 
their charge differences. The solvent gradient used was from 100% Milli-Q water 
to 20% IM of sodium chloride solution in 60 minutes and the flow rate was set at 0.5 
ml/min. Pullulan was used as a neutral polysaccharide standard while pectin was 
used as a standard with charged groups. Each sample or standard was allowed to 
run for 70 minutes and signals were detected by RI detector. 
2.2.4 Linkage analysis by methylation 
The linkages of the monosaccharides in the mushroom polysaccharides were 
determined by methylation analysis according to the procedures of Harris et al. (1984) 
as modified by Mukerjea et al. (1996). 
2.2.4.1 Preparation of partially methylated polysaccharides 
Molecular sieve was heat-activated at 550°C in the furnace for 5 hours and 
allowed to cool down at room temperature, and kept in a round bottomed flask 
flushed with nitrogen. Dimethyl sulfoxide (DMSO) was added into the above flask 
containing the molecular sieve under nitrogen, tightly wrapped in dark and stored at 
4°C. Dry DMSO was obtained due to the ability of molecular sieve to remove 
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moisture. 
Ten grams of sodium hydride (originally stored in oil) were weighed into 
polythene tubes containing hexane and were washed six times at 3000 rpm each for 5 
minutes to remove the oil. A 3-necked round bottom flask was continuously 
flushed with argon and one of the necks was connected to dried silica gel. Hexane 
was added to sodium hydride to resuspend the pellet in the polythene tube and the 
mixture was transferred to the round bottomed flask flushed with argon to vaporize 
excessive hexane. Once the sodium hydride was dried, 30 ml dried DMSO drawn 
by a glass syringe was slowly added into the flask. Dried DMSO and sodium 
hydride were allowed to react under argon until the color of this mixture turned into 
grayish-green. When the reaction was subsided (no more effervescence observed), 
it was transferred into small screw-capped glass bottles with Teflon and stored at - 2 0 
Before the methylation procedures, 4 mg of sample was weighed into 
screw-capped bottle for drying overnight under vaccum with both silica gel and 
phosphorus pentoxide ( P 2 O 5 ) to remove moisture thoroughly from samples. The 
dimethylsulfinyl methyl sodium (CH3SOCH2"Na+) was thawed before methylation. 
One milliliter of dry DMSO was added with a glass syringe into the screw-capped 
bottles containing samples under argon. The mixture was vortexed and sonicated at 
room temperature for 30-50 minutes. 
If the samples were soluble in DMSO, 0.4 ml of dimethylsulfinyl methyl 
sodium was added using a dry glass syringe under argon and the mixture was 
vortexed. The resulting gel would be liquefied by sonication for 60-90 minutes at 
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25°C followed by the addition of 0.3 ml of cold methyl iodide and was further 
sonicated for 15-20 minutes. The reactants were kept at room temperature for an 
additional 2 hours (or overnight). 
On the other hand, if the samples were insoluble in DMSO, a premethylation 
process would be necessary in which 20 [i\ of dimethylsulfinyl methyl sodium was 
added and the solution was kept in an ice bath until frozen. Then, 5 [il of ice-cooled 
methyl iodide was added to the frozen mixture, followed by 60 |il of dimethylsulfinyl 
methyl sodium and the mixture was kept in ice bath again until frozen. Once more, 
15 |il of ice-cooled methyl iodide was added to the frozen mixture and 0.4 ml of 
dimethylsulfinyl methyl sodium solution was added using a dry glass syringe along 
with vortex mixing. Similar to the previous part, the resulting gel was liquefied by 
sonication for 60-90 minutes at 25°C followed by the addition of 0.3 ml of cold 
methyl iodide and further sonication for 15-20 minutes. The reactants were then 
kept at room temperature for another 2 hours or overnight. 
After the above methylation process, 0.3 ml of water was added to neutralize 
excess methylsulfinyl methyl sodium. This resulting suspension was transferred 
into 15 ml polythene tubes so that the methylated polysaccharides could be extracted 
with 4 ml chloroform. The chloroform layer was washed with 3ml water and 
centrifuged at 3000 rpm for 5 minutes. The upper water layer was removed and 
discarded; the lower chloroform layer was washed 3 times with 3 ml water and the 
upper would be discarded each time after washing. After the last washing, any 
remaining water was removed by the addition of 3 ml 2,2-dimethoxypropane and 40 
fil glacial acetic acid. The solvent was then removed by evaporation under nitrogen 
at 40°C • The resulting methylated polysaccharides would be stored at 4°C. 
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2.2.4.2 Preparation of partially methylated alditol acetates (PMAAs) 
Subsequent to the above methylation procedures, 0.6 ml of 2M trifluoroacetic 
acid was added to the methylated polysaccharides and each tube was flushed with 
nitrogen. The mixture was heated for 1 hour at 120°C. The sample was then 
cooled down and placed in a 40°C water bath so that the solvent was evaporated to 
dryness under nitrogen. Next, 0.5 ml of 12M ammonia was added to samples and 
mixed thoroughly. If the pH of mixture was still acidic or neutral, more ammonia 
should be added until the pH was at least about 8. Allose was added as internal 
standard with an amount of 1 mg per tube. Following to the addition of 5 of 
octan-l-ol, 0.2 ml of 200 mg/ml sodium borohydride was added,and the mixture was 
kept at 40°C for 30 minutes. After that, 0.4 ml of glacial acetic acid was added and 
the mixture was vortexed. Then, 0.2 ml of sample was transferred to a new test 
tube followed by the addition of 0.3 ml of 1-methylimidazole and 2 ml of acetic 
anhydride. The resultant mixture was left at room temperature for 10 minutes. 
Five milliliters of distilled water was added, the mixture was vortex-mixed and 
cooled under running water to room temperature. One milliliter of dichloromethane 
was added, vortex-mixed and the tube was allowed to stand for 10 minutes for phase 
separation. The upper layer was discarded while the bottom layer was washed with 
2 ml distilled water twice. The final bottom layer was dried with anhydrous sodium 
sulfate and stored at -20°C for later GC-MS analysis. 
2.2.4.3 Gas chromatography-Mass spectrometry (GC-MS) analysis 
The above PMAAs were analyzed by a GC-MS spectrometer (Hewlett-Packard) 
using HP-5MS capillary column (5% phenyl methyl siloxane, 30m x 0.25mm i.d.， 
.•； 
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Hewlett-Packard) and oven temperature program of initial temperature 130°C， 
followed by a temperature rise of 4°C/min to 280°C with the interface temperature at 
250°C and split ratio at 30:1. The injector were at 280°C. The carrier gas was 
helium and detection was by MS. The ion source temperature of MS was at 250°C 
with ionization energy at 70 eV，detector volts at 1.5 kV and mass range from 50 to 
350. Each PMAA was identified by matching its mass spectrum with known 
standards and quantified after corrections for PMAA molar response factors, 
according to the effective carbon-response theory (Sweet et al., 1975). 
2.2.5 Determination of total sugar by phenol-sulphuric acid Method 
The samples, which were hydrolysate obtained previously from acid 
depolymerisation (2.2.2.1)，were diluted 50 times in 2 M concentrated sulphuric acid 
before the analysis. Then, 0.5 ml of diluted sample solution was vortex-mixed with 
0.5 ml of 5% phenol in water. After the addition of 2.5 ml of 18 M concentrated 
sulphuric acid rapidly from a glass dispenser, the mixture was vortex-mixed, and was 
allowed to stand for 30 minutes at room temperature. The amount of sugar was 
measured by reading absorbance at 490 nm (Dubois, 1956). A calibration curve 
was prepared by using a set of glucose standard of concentrations 100 |_ig/ml，50 
M-g/ml, 25 i^g/ml and 12.5 ^ig/ml. The formula of calculating the % total sugar was 
shown below: 
Cone, of total sugar from standard curve (|ig/ml) x 4.2ml x 50* 
% Total sugar = x 100% 
Sample weight (|ig) 
* A 50 times dilution was made in the above procedures 
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2.2.6 Determination of acidic sugars by measurement of uronic acid content 
The uronic acid content was determined colorimetrically according to Official 
Methods of Analysis (45.4.11) (AOAC，1996). An aliquot of hydrolysate (0.3 ml) 
was obtained previously from the acid depolymerisation (2.2.2.1)，added to a sodium 
chloride / boric acid solution (0.3 ml, dissolving 2 g sodium chloride and 3 g boric 
a d d in 100 ml distilled water) and the mixture were vortex-mixed. Five milliliters 
of 18 M concentrated sulphuric acid was added to the mixture with vortex mixing. 
The mixture was kept at 70°C for 40 minutes. After cooling the mixture to room 
temperature, dimethylphenol [0.2 ml, dissolving 0.1 g 3,5-dimethylphenol (TCI, 
Tokyo, Cat. # D0778) in 100 ml glacial acetic acid] was added. The mixture was 
vortex-mixed and stood at room temperature for 10 minutes. Next, 2 M sulphuric 
acid was used as blank and glucuronic acid standards of concentrations 10 |ig/ml, 50 
|ig/ml，100 i^g/ml, 200 gg/ml and 500 ^ig/ml were prepared and treated similarly as 
samples. Absorbance of the sample solutions at 400 run and 450 nm against the 
blank were measured. The reading at 400 nm was subtracted from 450 nm to 
correct for the interference from hexoses. The uronic acid content was calculated 
using D-galacturonic acid monohydrate as the standard ad expressed as a 
polysaccharide residue by multiplying a factor of 0.89 (Scott, 1979). The formula 
of calculating the % acidic sugar was shown below: 
Cone, of acidic sugar from standard curve (|ig/ml) x 4.2ml* 
% Acidic sugar = — x 100% 
Sample weight (^g) 
*This was the final total volume of the reaction mixture 
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2.2.7 Determination of protein content by Lowry-Folin method 
Lowry reagent solution (Sigma, Cat. # L3540) and Folin & Ciocalteu's Phenol 
Reagent Working Solution (Sigma, Cat. # P5656) were prepared according to the 
instructions in the manual. The Lowry-Folin method (Lowry et a l , 1951) was used 
to determine the protein content. 
Protein standard solutions with different concentrations, ranging from 25 to 200 
l^g/ml were prepared by adding distilled water to protein standard to a final volume 
of 1.0 ml. Sample solution was added to test tube and diluted 5 times to 1.0 ml with 
water. One milliliter of Lowry reagent solution was added to all standard, sample 
and blank tubes and mixed well. After that, the solutions were allowed to stand for 
20 minutes at room temperature. Then, 0.5 ml of Folin & Ciocalteu's Phenol 
Reagent Working Solution was added to each tube with rapid and immediate mixing 
allowed color development for 30 minutes. Solutions were transferred to cuvettes 
and absorbance was measured at 750nm against blank. Calibration curve was set 
according to protein standard solutions and original protein content of each sample 
was determined correspondingly from the curve and by multiplying an appropriate 
dilution factor. 
Cone, of protein from standard curve (|ig/ml) x 1 ml x 5* 
% Protein = x 100% 
Sample weight (|ig) 
* A 5 times dilution was made in the above procedures 
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2.2.8 Chemical modiflcation by carboxymethylation 
Crude extracts including all native fractions of PT, sonication fractions of PC 
and PR were carboxymethylated according to the procedures for carboxymethylating 
p-glucan (Sasaki et al., 1979). One gram of crude extract was added into 27.5 ml of 
isopropanol and the mixture was stirred for 30 minutes to get a suspension. The 
suspension was then mixed with 27.5 ml of 30% sodium hydroxide and stirred 
initially for 60 minutes, followed by a further vigorous 90 minutes stirring. Then, 
1.25g of monochloroacetic acid was added to the suspension and the mixture was 
allowed to react at 60-70°C for 90 minutes to form a solution. The solution was 
washed with methanol/acetic acid (7:3 v/v)，methanol/water (4:1 v/v), methanol and 
lastly acetone. This final precipitate was redissolved in water and dialyzed against 
running water before lyophilization. 
2.2.9 In vitro antitumor assay 
For suspension cells, 100 i^l of 2.5x10^ cells/ml with sample in medium (RPMI 
1640 for HL-60 cells and DMEM for K562 and SI80 cells) were added to 
round-bottomed 96-well plate (Sarstedt, Cat. # 83.1835.500); while for adhesive cells, 
100 \i\ of 2.5x103 cells/ml were seeded on flat-bottomed 96-well plate (Sarstedt, Cat. 
# 83.1835) 24 hours before the addition of control and samples in medium (RPMI 
1640 for MCF-7, HepG2 and VERO cells) to be tested. Six concentrations of 
mushroom polysaccharides varied from 12.5 |ig/ml to 400 ^ig/ml were set with 
medium as control, trypan blue exclusion assay and MTT assay was used for testing 
the cell viability for suspension cells and adhesive cells, respectively. 
.•c 
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2.2.9.1 Trypan blue exclusion assay 
Different concentrations (12.5 |j,g/ml to 400 昭/ml) of mushroom 
polysaccharides were added to the cell suspensions and mixed with equal volume of 
trypan blue dye (0.4% in PBS; BDH Chemicals Ltd., England, Cat. # 34078)，i.e. 0.1 
ml of cell was mixed with 0.1 ml of dye and 10 [il of these stained cells was drawn 
onto the hemocytometer. The living cells, not being stained, of each fraction were 
counted (sample cell number) and compared with the control cell number to calculate 
the inhibition ratio by the formula below: 
(Control cell number - Sample cell number) 
Inhibition ratio (%) = x 100% 
Control cell number 
2.2.9.2 MTT Assay 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MTT (Sigma, 
Cat. # M5655) assay (Mosmann, 1983) was carried out to assess the viability of 
adhesive cells. At the termination of the experiments (72 hours later), MTT (50 
l^g/lOO |il sample) were added to the wells and incubated for 5 hours at 37°C. After 
aspirating MTT solution, the blue formazan reaction product was extracted with 150 
1^1 isopropanol and was mixed well with a multi-channel pipette. Then, the 
absorbance was measured at a wavelength of 570nm. The density of living cells of 
each fraction were compared with the control to calculate the inhibition ratio by the 
formula below: 
(Control absorbance — Sample absorbance) 
Inhibition ratio (%) = x 100% 
Control absorbance 
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2.2.10 Cell cycle analysis by Flow Cytometry 
Cells were placed on 6-well tissue culture plate (Sarstedt, Cat. # 83.1839) at a 
density of 2x10) cells/ml in order to allow triplicate measurements for both control 
and treatment group. Different amount of culture medium (RPMI 1640 for HL-60 
cells and DMEM for K562 cells) was added to a final volume suitable for growing 
cells for 24，48 and 72 hours. Then, different amount of crude extract dissolved in 
culture medium was added accordingly in order to find out the effective 
concentration for reducing about 50% growth of cells. This concentration was 
determined by adding six concentrations of samples to cells from 12.5|^g/ml to 
400|ig/ml for in vitro assay so that a particular concentration of sample was 
responsible for growth inhibition of cells by about 50%. After 24，48 or 72 hours, 
cells were harvested by transferring them to polystyrene tubes and centrifliged at 
2000 rpm for 5 minutes. Cell pellets were collected with the removal of culture 
medium and were washed twice with 2 ml of IX PBS at 2000 rpm for 5 minutes. 
Following to the removal of last drip of PBS, 2 ml of ice cold 70% ethanol was 
added to resuspend the cell pellet for fixation. The cell suspension was kept at -20 
°C until staining. 
Cell suspension was first spinned down at 2000 rpm for 5 minutes to remove 
ethanol. Cells were washed twice again with 2 ml'of IX PBS at 2000 rpm for 5 
minutes. One milliliter of propidium iodide (PI) [0.121g/dL of Tris, 0.005g/dL of 
PI (Sigma, Cat. # P4170) adjusted to pH 8.0 and O.OOlg/dL ofRNase A (Sigma, Cat. 
# R4875)] was then added to resuspend cell pellet subsequent to the removal of last 
drop of PBS. The Pl-stained cell suspension was transferred to a tube specifically 
for flow cytometry by passing through 4 0 网 nylon mesh beforehand to prevent 
；c 
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formation of clumps. The tube containing filtered cells was kept at 4°C before 
carrying out flow cytometry analysis (Loken and Stall, 1982). Cells were analyzed 
for DNA content using flow cytometer (Beckman Coulter, XL-MCL，USA). The 
distribution of cells in sub-Gi, Gi, S and G2-M was determined using MultiCycle 
Analysis AV software (Phoenix Flow Systems, San Diego, CA). The sub G! peak was 
regarded as an indicator of the onset of apoptosis. 
2.2.11 In vivo antitumor and immunomodulatory assay 
2.2.11.1 Measurement on tumor growth 
On day zero, 7-8 weeks old male BALB/c mice were weighed and were then 
placed in the animal house. After that, 0.2ml of 5 x 10^ cells of the solid tumor -
Sarcoma S-180 was implanted at the back of each mouse. For the subsequent 10 
days (day 1 to day 10), 0.2ml of mushroom extracts of 20 mg/kg of body weight or 
PBS as the control were injected into the peritoneal cavity of the mice (10 mice per 
group). The mice were then maintained with rat chow and water in the animal 
house for 7 days. On day 19, the mice were terminated and the tumors at the back 
were cut off for weighing. The weight of the tumors from each group was averaged 
and compared with that of the control group to calculate for the inhibition ratio as 
below: 
(Control tumor weight - Sample treatment tumor weight) 
Inhibition ratio (%) = x 100% 
Control tumor weight 
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2.2.11.2 Blood sampling for immunostimulatory effects 
Eight male BALB/c mice with or without implanted tumor were used for 
immunostimulatory studies. After ten days of intraperitoneal injection of PR-W 
with doses of 5 mg/kg and/or 50 mg/kg body weight, the animals were restrained to 
become sedentary and 70% ethanol was used as vasodilator in wiping their tails. 
Then, 0.2 ml of lipopolysaccharides, LPS [from E. coli serotype 0111:B8, (Sigma 
Cat. # L-4391)’ 50 jig/ml PBS] (as a cytokine priming agent) was injected 
intravenously into the tail. One hour after injection of LPS, the mice were made 
unconscious by diethyl ether and blood was drawn by heart puncture. Blood was 
also drawn from another group of mice without LPS priming action. Blood drawn 
from all these mice was allowed to clot on ice and sera isolated by centrifugating at 
12000 rpm for 5 minutes twice were kept for the cytokine assay. 
2.2.12 Mouse Cytokine Array 
RayBio® Mouse cytokine array II (RayBiotech, Cat. # 0308002) was used for a 
multiple detection of cytokines (Wang et al., 2002). Thirty-two different cytokine 
antibodies were precoated on array membranes. Each membrane would first be 
placed into an eight-well tray and 2 ml of IX blocking buffer was added to incubate 
for 30 minutes to block the membrane. After decanting the blocking buffer, 1 ml of 
diluted serum (10-fold dilution with IX blocking buffer) was added for a further 
incubation of 1 to 2 hours at room temperature. Mouse serum was then removed 
and the membrane was washed 3 times with 2 ml of IX wash buffer I at room 
temperature with shaking for 5 minutes each. The membrane was washed twice 
with 2 ml of IX wash buffer II at room temperature with shaking for 5 minutes each. 
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One milliliter of diluted biotin-conjugated anti-cytokines was added to each 
membrane and was allowed to incubate for 1 to 2 hours. Then, the membrane was 
washed again as mentioned before with wash buffer I and II, Next, 2 ml of 
1000-fold diluted HRP-conjugated streptavidin was added to the membrane and 
incubated for 2 hours. The membrane was washed yet again as stated before and 
prepared for subsequent detection processes. 
Two different detection buffers were mixed and 500 |il of this mixture was 
added to each membrane and incubated for 2 minutes at room temperature. Excess 
detection buffer mixture was drained off and the membrane was covered with plastic 
sheet. The membrane was then exposed to x-ray film and signal could be detected 
using film developer. 
2.2.13 Quantification of Mouse IL-13 by ELISA 
Enzyme linked immunosorbent assay (ELISA) was used in quantifying the 
amount of IL-13 present in serum. RayBio® Mouse IL-13 (RayBiotech, Cat. # 
ELM IL-13-001) ELISA kit was used for this purpose. All the reagents in the kit 
were brought to room temperature before use. In order to prepare the standard, 
assay diluent A (animal serum with 0.09% sodium azide as preservative) was first 
added to a vial containing powdered standard to dissolve it thoroughly and became a 
reserve of 0.5 \xg/ml Then, 8 |il of IL-13 standard was added to a tube of 658.7 \i\ 
assay diluent A in order to prepare a stock standard of 6000 pg/ml. Serial dilution 
was performed to produce a dilution series and assay diluent A was served as the 
zero standard. 
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Every sample (serum) was diluted ten-fold with assay diluent A and both 
standards and samples were prepared in duplicate. For each well, 100 iil of each 
standard or sample was added and incubated for 2.5 hours at room temperature. 
The solution was discarded and each well was washed 4 times with 200 jil IX wash 
solution. Biotinylated antibody was diluted 500-fold to IX with assay diluent B 
(concentrated buffer) so that 100 was added to each well and incubated for 1 hour 
at room temperature. The solution was discarded and each well was washed 4 times 
with 200 |il IX wash solution. HRP-Streptavidin concentrate was diluted 2000-fold 
to IX with assay diluent B so that 100 [i\ was added to each well and incubated for 
45 minutes at room temperature. The solution was discarded and each well was 
washed 5 times with 200|al IX wash solution. In order to develop the signal, 100 
of 3,3',5,5'-tetramethyIbenzidine (TMB) one-step substrate reagent was added to 
each well and incubated for 30 minutes at room temperature in the dark. Finally, 50 
|Lil of stop solution (2M sulfuric acid) was added to each well and the absorbance was 
measured at 450 nm immediately afterwards. In order to quantify the IL-13 content 
in mouse serum, the absorbance reading of sample was recorded and calculated 
according to a calibration curve constructed by IL-13 standards. 
2.2.14 Enumeration of peritoneal cells 
To study the immunomodulatory effects of crude mushroom extracts, no tumor 
was implanted on the male BALB/c mice. During the 10-day course of treatment of 
injecting crude extracts intraperitoneally to mice, one milliliter of 3% thioglycollate 
broth (Difco, USA) was injected intraperitoneally into the mice three days before 
termination of mice for the isolation of peritoneal cells. The peritoneum of each 
mouse was washed with 6 ml PBS in which 5 ml of peritoneal cells were collected. 
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The collected cells were washed twice with RPMI 1640 medium at 1000 rpm for 5 
minutes. The cell pellet was then resuspended with complete RPMI 1640 
containing 10% heat-inactivated FBS，1% penicillin and streptomycin at a cell 
concentration of 2x10^ cells/ml. The cells were then transferred to a culture T flask 
and were allowed to adhere for 3 hours at 37°C in a CO2 incubator. After that, the 
cells were washed three times with RPMI 1640 to remove any non-adherent cells in 
the flask. The adherent cells were trypsinized, collected and resuspended in 1 ml of 
complete RPMI 1640. Cell viability of adherent cells was then assessed using 
trypan blue exclusion assay (section 2.2.9.1) with a cell concentration at 1x10^ 
cells/ml per tube. The cells were then centrifuged again to remove residual medium 
and 3 ml of wash buffer, containing IX PBS, 0.1% sodium azide and 1% bovine 
serum albumin (BSA), was added to wash the cells at 2000 rpm for 5 minutes. 
In order to stain cells for macrophages, 25 pi of diluted purified anti-mouse 
CD 16/32 (working concentration should be smaller than or equal to 1 jig per million 
cells; Pharmingen, Cat. # 01241D) was added into each tube and incubated in an ice 
bath for 5-10 minutes. Then, 25 of diluted phycoerythrin (PE)-Rat IgGl, k 
isotype control (Pharmingen, Cat. # 553925) or PE-conjugated anti-mouse Mac-3 
(M3/84) (Pharmingen, Cat. # 553324) was added and kept for 30 minutes in an ice 
bath in darkness with constant shaking during incubation. On the other hand, for 
the staining of natural killer cells, it was unnecessary to add CD 16/32 but, 25 i^l of 
diluted PE-Rat IgG2a, k isotype standard (Pharmingen, Cat. # 553930) or 
PE-anti-mouse NK 1.1 (Pharmingen, Cat. # 01295A) was added instead with a 30 
minutes incubation in an ice bath in darkness with constant shaking during 
incubation. Finally, 0.5 ml of wash buffer was added to each tube before analyzing 
by a flow cytometer with the program as mentioned before (section 2.2.10). 
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2.2.15 Enumeration of splenocytes 
After the isolation of peritoneal cells (section 2.2.14), the spleens of each treated 
or control male BALB/c mouse was isolated aseptically in laminar flow cabinet and 
placed into petri dish pre-added with DMEM. While keeping ducts intact, 5 ml of 
PBS was injected into the spleen to rinse cells out and these splenocytes were 
washed at 1500 rpm for 5 minutes. All splenocytes were resuspended in complete 
DMEM containing 10% heat-inactivated FBS, 1% penicillin and streptomycin at a 
cell concentration of 3x10^ cells/ml. Splenocytes were transferred to culture T flask 
and were allowed to adhere overnight at 37°C in a CO2 incubator. On the next day, 
splenocytes were subfractionated into adherent and non-adherent cells. Suspension 
cells were first collected and the adherent cells were then trypsinized, collected and 
resuspended in 1 ml of complete DMEM. Cell viability of adherent cells was 
assessed using trypan blue exclusion assay with a cell concentration at 1x10^ cells/ml. 
The cells were then centrifuged again to remove residual medium and 3 ml of wash 
buffer, containing IX PBS, 0.1% sodium azide and 1% bovine serum albumin (BSA), 
was added to wash the cells at 2000 rpm for 5 minutes. 
In staining for CD4+ and CD8+ T lymphocytes, 25 |il of diluted purified 
anti-mouse CD 16/32 was first added to each tube and incubated for 5-10 minutes. 
Then, 25 [i\ of diluted fluorescein isothiocyanate (FITC)-anti-mouse CD3 molecular 
complex (Pharmingen, Cat. # 555274) was added to each tube following by the 
addition of either PE-anti-mouse CD4 (Pharmingen, Cat. # 553049) or 
PE-anti-mouse CD8a (Pharmingen, Cat. # 01045B) and their control, PE-Rat IgG2a, 
k isotype standard to different sample and control tubes. These tubes were 
incubated for 30 minutes in an ice bath in darkness and with constant shaking. 
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Finally，0.5 ml of wash buffer was added to each tube before analyzing by a flow 
cytometer with the program as mentioned before (section 2.2.10). 
2.2.16 Statistical methods 
All analyses were performed in triplicate. The data were recorded as 
mean土standard deviations and analyzed by SPSS (Version 11.0 for Windows 98， 
SPSS Inc.). The mean values of both in vitro and in vivo antitumor activities 
between sample and control were analyzed by student's t-test. Differences between 
means at 5% (p < 0.05) level were considered to be significant. 
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Chapter 3. Results and Discussion 
3.1 Yield of crude mushroom sclerotial extracts 
Referring to hot water extraction scheme (section 2.2.1.1), the yield of extracts 
by hot water alone was found to be 3.62% of PT-W, 2.38% of PC-W and 8.62% of 
PR-W in which PR-W had the highest yield. Yield of PR-W was double that of 
PT-W and PC-W (Table 3.1). 
Referring to the sequential extraction scheme (section 2.2.1.2), the yield of 
sonication fraction (PC-SON) from Poria cocos (76.97%) and that from Polyporus 
rhinocerus (PR-SON) (73.14%) was extremely high. In contrast, sonication was 
found to be less effective in extracting soluble materials from Pleurotus tuber-regium 
sclerotia (only 12.43%) (Table 3.1). Among different solvent extractions, yields of 
the hot water extract (HWE), cold alkali (CAE) and hot alkali (HAE) extracts in all 
three sclerotia were very low (ranged from 0.4% to 3.8% only) except PT-CAE and 
PT-HAE which had 20% and more (Table 3.1). 
Traditionally, hot water is usually used as a medium for extraction of bioactive 
substances from mushrooms which had potent activity in treating various kinds of 
diseases (Mizuno, 1999). Hot water extract with potent antitumor activity against 
Sarcoma S-180 tumor in Swiss albino mice had been obtained from the fruitbody of 
six edible mushrooms, including Flammulina velutipes, Lentinus edodes, Pholiota 
nameko, Pleurotus ostreatus, Pleurotus spodoleucus and Tricholoma matsutake 
which all belonged to Basidiomycetes (Ikekawa et al., 1968). Lentinan, a hot water 
extract from Lentinus edodes, was also effective against Sarcoma S-180 transplanted 
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in CD-I/ICS mice (Chihara et al., 1969). Since then, there were a lot of findings 
about hot water extracts from mushrooms against different kinds of tumor cells. 
Therefore, the first extraction solvent used for extracting mushroom sclerotia in this 
project was hot water alone. The hot water alone extraction method usually has a 
relatively lower yield as water is not a very good solvent for the biologically active 
polysaccharides in mushrooms, which have poor water solubility. The yield of 
Lentinan from Lentinus edodes was only 0.16% by hot water extraction (Chihara et 
al.，1970a, b), and that of the three sclerotia used in the present study already had a 
higher yield of about 2-9%. 
Sclerotia had a more rigid cell wall structure (Stamets, 1993) than fruit bodies 
and mycelia. Therefore, more vigorous conditions should be applied in order to 
‘extract a better yield of biological active polysaccharides. Previous results have 
shown that sclerotia contained (3-glucans of which the majority was water-insoluble 
(Marchessault et al., 1977). When diluted alkali was used as the extraction solvent, 
the amount of water-insoluble P-D-glucan obtained was much greater than the 
water-soluble (3-D-glucan obtained by hot water extraction (Mizuno, 1999). In 
order to enhance the yield of mushroom extracts, especially the p-D-glucan, 













































































































































































































































































































































































































































































































































Table 3.2 Chemical composition of the carboxymethylated mushroom sclerotia 
Sclerotia Fractions % Total carbohydrate % Uronic acids % Protein 
Sonication 
84.39 0.999 n.d. 
(CMPT-SON) 
Hot water 




(PT) 86.22 1.375 n.d. 
(CMPT-CAE) 
Hot alkali 
99.09 1.244 n.d. 
(CMPT-HAE) 
Poria cocos Sonication 




rhinocerus 88.68 0.546 n.d. 
(CMPR-SON) 
(PR) 
n.d. not determined 
Sonication in the sequential extraction scheme used in here is a method 
combining the use of dilute alkali and sound wave energy. The sclerotia were 
swollen in alkali before sonication took place. Sonication provides a physical 
means of extraction in which the ultrasonic waves supply energy to break the 
non-covalent bonds between the P-glucan-chitin complexes (Chen et al., 1997). 
Such bonding in the fungal cell wall is present in large amount in chitinous materials 
since cell walls of basidiomycetes have cellulose and chitin co-existing as structural 
components (Bartnicki-Garcia, 1970). Sonication helps the breakdown of the cell 
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wall in order to facilitate subsequent extraction. In addition, physical treatment 
such as sonication, usually leads to a reduction of molecular weight (Adachi et al., 
1990b). Particularly, sonication could lead to a reduction of molecular weight 
without deacetylation in the chitosan being sonicated (Wang and Lin, 1990). The 
yield of glucan-cihtin complex was found to be increased after sonication as 
determined by phenol-sulphuric acid method (Mislovicova, 2000). Therefore, the 
reason why sonication could give a high yield of extract for PC and PR might be due 
to the breakdown of chitinous materials in the cell wall and hence facilitating the 
extraction of polysaccharides within the inner layer of the flingal cell wall. 
The use of alkaline solution for extraction increased the solubility and thus the 
yield of alkaline-soluble polysaccharides from the mushroom sclerotia (Table 3.1). 
Specifically, P-(l一3)-D-glucan had a better solubility in alkaline solution due to the 
disruption of the ordered conformation by the alkali (Saito et a l , 1987). 
The use of carboxymethylation, as mentioned earlier (section 2.2.8)，enhanced 
the water solubility of native water-insoluble sclerotial fractions (Table 3.2) and the 
yield of all CM-glucans was over 70% (data not shown). 
The above extraction method involved the use of hot water, sonication, cold and 
hot alkali that consisted of both physical and chemical treatments. The use of 
different extraction solvents might help to obtain homogeneous fractions from the 
heterogeneous materials in the mushroom sclerotia. Furthermore, the different 
treatments including high temperature, ultrasonic energy and alkaline might 
influence the change in the conformation of j3-(l—3)-D-glucan into random coil, 
single helix and triple helix (Yadomae and Ohno, 1996). 
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As mentioned earlier (section 1.4)，the structure-activity relationship of 
3)-D-glucan can be affected by parameters including molecular mass, linkage, degree 
of branching and conformation. These parameters in turn, can also be influenced by 
the extraction methods used. In general, there are three main type of conformations 
in (3-(l—3)-D-glucan，namely, triple helix, single helix and random coil (Mizuno et 
al., 1995a). The formation of helical structure in polysaccharides is achieved by the 
presence of inter- and intra-chain interactions. The inter-conversion between triple 
helix and single helix can be mediated by different chemical and physical treatments. 
Upon the addition of alkali, glucan would become a random coil (Ogawa et al., 1972). 
When the alkali was removed by neutralization, dilution or dialysis, single helix 
conformation appeared in the p-glucan (Yadomae and Ohno, 1996; Sawai et al., 
2002). The neutralization of alkali by HCl would lead to the formation of gels in 
which linear P-(l->3)-D-glucan that had single-helix conformation would form an 
elastic gel, while branched p-(l—3)-D-glucan that had triple-helix conformation 
would form a brittle gel (Harada, 1977). 
On the other hand, glucan adopts a random coil conformation under high 
temperature but change to a single helical conformation upon the lowering of 
temperature. Some of the glucans finally formed triple helix as a more stable 
conformation after the above-mentioned physical and chemical treatments (Yadomae 
and Ohno, 1996). The sclerotial P-glucans obtained from above by ultrasonication, 
cold and hot alkali extractions gradually formed gels during dialysis which indicated 
that a helical conformation was adopted with the removal of physical treatments and 
alkalis. Alkali extracts of PC was known to have a linear p-glucans structure that 
would most likely to have single-helix conformation, while these sonicated and alkali 
fractions of PT and PR that have highly branched glucan would have triple-helix 
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conformations. The hot water extracts of the mushroom sclerotia were presumably 
to have a single-helix conformation as the lowering of extraction temperature usually 
led to this conformation of p-glucans. 
3.2 Chemical composition of crude mushroom sclerotial extracts 
3.2.1 Total carbohydrate content 
The total carbohydrate content was determined by phenol-sulphuric acid assay 
using glucose as a standard for constructing a calibration curve. The total 
carbohydrate content found in these mushroom sclerotial extracts varied greatly from 
15.14% to 99.02%, implying that the co-existence of other non-carbohydrate 
substances during the extraction of mushroom sclerotial extracts (Table 3.1). 
The hot water alone extracts of PT (PT-W) and PR (PR-W) had less than 40% 
carbohydrate content when compared with other PT and PR fractions. This might 
indicate that other substances, for example, protein was present in a very substantial 
amount in these extracts. In the case of PC-W, carbohydrate was still the dominant 
substance (65.09%) present (Table 3.1). 
In the case of PT, the carbohydrate content resulting from both cold and hot 
alkali extractions was relatively higher (more than 90%) than that from sonication 
and hot water extraction (more than 60%) (Table 3.1). This pattern was similar to 
the extraction yield in which the yield of alkali extraction was higher than that of 
sonication and hot water extraction (Table 3.1). Therefore, alkali extractions were 
effective in extracting polysaccharides from PT. 
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In the case of PC and PR, both sonication fractions had the highest carbohydrate 
content of 94.75% and 82.26%, respectively (Table 3.1). Within the sequential 
extraction scheme, there was a general trend that carbohydrate content gradually 
decreased from the first to the last fractions (Table 3.1). 
3.2.2 Uronic acid content 
The acidic sugar of different fractions was determined by the uronic acid 
method. In general, all fractions consisted of very low percentage (0.474% to 
2.719%) of or even no acidic sugar (Table 3.1). Among all the fractions, sonication, 
hot water extracts and cold alkali extracts from PT had a relatively higher percentage 
of uronic acid (but less than 3%). The PT-W had a particularly lower amount of 
acidic sugar among all native and carboxymethylated fractions (Tables 3.1 and 3.2). 
No acidic sugar was found in CAE and HAE of PC. This was consistent with 
previous findings that the uronic acid content in mushroom polysaccharides was 
usually very low, especially with P-glucans. In mushroom polysaccharide other 
than p-glucan, a water-insoluble xyloglucan fractions from Grifola frondosa had a 
glucuronic acid content of 16.5% (Mizuno, 1986). 
3.2.3 Soluble protein content 
The soluble proteins of all fractions were determined by the Lowry-Folin 
Method. The hot water alone extracts, including PT-W, PC-W and PR-W were 
found to have a much higher protein content compared with their corresponding 
native or carboxymethylated fractions (Table 3.1 and 3.2). PT-W had a protein 
content of 66.59%, which was in good agreement with its low carbohydrate content 
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of 34.89%. No protein was determined in CAE, HAE and carboxymethylated as 
their total carbohydrate content was nearly 100%. 
Only PC-W and hot water extracts from PC (PC-HWE) contained a low level of 
protein (4.115% and 14.17%, respectively). This matched with total carbohydrate 
content of these two fractions in which PC-W had a higher total sugar (65.09%) than 
PC-HWE (32.11%). No protein was found in other fractions of PC because these 
fractions had poor water solubility and thus no soluble protein could be determined 
by this method. 
PR-W had the highest protein content (41.27%) among all PR fractions. The 
hot water extracts from the sequential extraction scheme was not determined due to 
insufficient amount of samples. Similar to PT-W, PR-W had such a high percentage 
of protein that matched with a lower total sugar content of 37.42%. 
Protein was found to be dominant in all hot water extracts, particularly, PT-W 
and PR-W. When considering the monosaccharide profile of these two extracts, the 
amount of mannose was quite high (66.59% and 41.27%, respectively) implying the 
presence of mannoprotein (Reshetnikov et al., 2001). 
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3.3 Monosaccharide profiles of mushroom sclerotial extracts by GC 
All fractions from three mushroom sclerotia did not contain galactosamine 
which indicated for the absence of linkage between carbohydrate and protein 
(Biermann, 1990) (Table 3.3 to 3.5). On the other hand, a large amount of glucose 
(over 80%) was present in all fractions obtained from either hot water extraction 
alone or the sequential extraction scheme. For both PT and PR, the glucose content 
of hot water extracts (PT-W and PR-W) was relatively (about 10%) lower than those 
fractions obtained from PT and PR by the sequential extraction scheme (Table 3.3 to 
3.5). However, the fact that the glucose content of PC-W was found to be similar to 
other PC fractions was due to its smaller amount of mannose (2.4%) than that in PT 
(13.9%) and PR (12.1%) (Table 3.3 to 3.5). Water-soluble extract from Ganoderma 
tsugae contained protein-containing heteroglycans with mannose (Reshetnikov et al., 
2001). The water-soluble fractions of Grifola frondosa contained 
fucogalactomannan-protein complex, a glucogalactomannan, a mannogalactofucan 
and a galactoflucomannofucan-protein complex in which mannose was the common 
sugar found among these complexes (Zhuang et al., 1994). The hot water extracts 
of the three mushroom sclerotia in our study all consisted of mainly of glucose with a 
considerable amount of mannose, implying the presence of water-soluble 
mannoglucan. 
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Table 3.3 Monosaccharide profile of various fractions of Pleurotus tuber-regium 
crude extracts (sugar composition indicated as %) 
Pleurotus tuber-regium (PT) 
PT-W PT-SON PT-HWE PT-CAE PT-HAE 
Rhamnose 0.00 0.00 0.39 0.59 0.36 
Fucose 0.00 0.12 0.00 0.00 0.00 
Ribose 0.79 0.44 0.00 0.00 0.00 
Arabinose 0.00 0.22 0.00 0.00 0.05 
Xylose 0.58 0.11 0.00 0.20 0.09 
Marmose 13.9 1.32 0.77 0.00 0.13 
Galactose 3.64 0.11 0.00 0.00 0.00 
Glucose 81.1 97.7 98.0 98.7 99.0 
Glucosamine 0.00 0.00 0.84 0.51 0.32 
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Table 3.4 Monosaccharide profile of various fractions of Poria cocos crude extracts 
Poria cocos (PC) 
PC-W PC-SON PC-HWE PC-CAE PC-HAE 
Rhamnose 1.10 0.12 0.00 0.00 0.00 
Fucose 1.74 0.00 0.00 0.00 0.00 
Ribose 0.87 0.11 0.07 0.46 0.00 
Arabinose 0.19 0.00 0.00 3.21 0.28 
Xylose 0.00 0.08 0.06 0.69 0.98 
Mannose 2.36 0.25 0.23 2.26 0.93 
Galactose 3.85 0.19 0.09 0.14 0.00 
Glucose 90.0 98.2 89.0 90.0 88.8 
Glucosamine 0.00 1.08 10.54 3.26 8.98 
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Table 3.5 Monosaccharide profile of various fractions of Polyporus rhinocerus crude 
extracts 
Polyporus rhinocerus (PR) 
PR-W PR-SON PR-HWE PR-CAE PR-HAE 
Rhamnose 1.04 0.00 0.36 0.28 0.11 
Fucose 0.00 0.00 0.00 0.00 0.00 
Ribose 1.84 0.00 0.34 0.08 0.00 
Arabinose 0.00 0.00 0.00 1.01 0.18 
Xylose 0.00 0.09 0.00 0.00 0.00 
Mannose 12.1 0.19 3.21 2.03 1.07 
Galactose 2.31 0.00 0.71 0.00 0.31 
Glucose 82.7 98.6 93.6 95.4 96.8 
Glucosamine 0.00 1.17 1.79 1.18 1.57 
Among the monosaccharides found, glucose was the major component in all 
sclerotial extracts. The glucose content was generally higher in extracts by cold 
alkaline extraction than by hot water extraction (Sawai et al., 2002). Similar 
findings was observed in these three mushroom sclerotia in which glucose content 
from sequential extraction scheme had more than 90% and that of hot water alone 
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extraction was only about 80% for PT and PR (except for PC which had 90%) 
(Table 3.3 to 3.5). This was because cold alkali solution was used in here (IM of 
sodium hydroxide solution for sonication; 4M of sodium hydroxide for cold alkali 
extraction). The glucose content of all sonication fractions was higher (about 10% 
in PC and more than 15% in both PT and PR) than that of hot water extracts alone, as 
sonication was the first step in the sequential extraction scheme using both cold 
alkali and ultrasonic energy. 
In addition, glucosamine was found in some of the fractions but not in hot water 
extracts alone. Glucosamine was detected as N-acetylglucosamine from chitin in 
fungal cell wall (Michell and Surfield, 1967). Chitin was found to be a kind of 
alkali-insoluble cell-wall component in Aspergillus niger (Rosenberger, 1976) and 
resembled the structure of cellulose (Knorr, 1984). A relatively higher level of 
glucosamine was detected in hot water extracts (HWE) following sonication in both 
PT and PC. The sonication process might promote deacetylation of chitin, releasing 
more chitosan (glucosamine) in the subsequent hot water extracts. 
Amount of marmose and galactose in hot water extracts alone were found to be 
relatively higher than other extracts. This pattern was more noticeable in PT-W and 
PR-W as their glucose content was also lower when compared to that of PC-W. 
More than 10% of mannose was found in PT-W and PR-W when compared with all 
other fractions, giving a lower amount of glucose in these 2 extracts (Table 3.3 and 
3.5). Such a high percentage of mannose in the extract indicated other substances 
other than carbohydrate, like proteins, was present. Therefore, Lowry-Folin method 
was performed to identify the amount of soluble proteins present in the extracts. 
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3.4 Chromatographic analyses of mushroom sclerotial extracts 
3.4.1 Molecular weight profile by size exclusion chromatography (SEC) 
TSK-Gel PW columns are commonly used in high performance size exclusion 
separations of industrial water-soluble polymers and oligosaccharides. The 
hydrophilic polymer matrix in these columns has excellent chemical and mechanical 
stability. Although commonly used with aqueous solvents, the polymer matrix is 
compatible with up to 50% organic solvent. PW-type resin is less hydrophilic than 
polysaccharide gels. Thus, addition of organic modifier or a decrease in salt 
concentration sometimes is needed to reduce hydrophobic interaction. TSK-Gel 
PW resins have a small residual negative charge (Supelco, 2000). 
TSK gel G5000PW column is packed with resin of 17)im particle size with 
1000A pores and the MW range for polyethylene oxide glycol/polyethylene oxide 
dimethylether (PEGS/PEOS) is 4-1000x10^ and for dextrans is 50-7000x1 
TSK gel G3000PW is packed with resin of lOp-m particle size with 200人 pores and 
the MW range for PEGS/PEOS is <50x10^ and for dextrans is <60x1 Ol 
Eight pullulan standards were used for determining molecular weight of hot 
water extracts from the three mushroom sclerotia. This set of standards is either a 
pullulan or polymaltotriose that is a linear polysaccharide consisting of maltotriose 
ranging from 0.59x10^ (P5), 1.18x10'^ (PIO), 2.28x10^ (P20), 4.73x10^ (P50), 
11.2x104 (PI00), 21.2x104 (P200), 40.4x10'^ (P400) and 78.8x10^ (P800). These 
standards were used to make up of a calibration curve for the two size exclusion 
columns - TSK G5000 and TSK G3000 [Fig. 3.1 (a), (b)] so that molecular weight 
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of extracts was determined accordingly. 
0.2M NaCI was used as the dissolving and eluting solvent in order to give an 
ionic strength that prevented aggregation of the extracts and provided better 
resolution than water (data not shown). TSK gel G5000 PW was first used for 
assessing the molecular weight of three hot water extracts alone (PT-W, PC-W and 
PR-W). It was found that molecular weight of these three extracts was generally 
low as the profile showed the retention time similar to that of standard P5 or between 
P5 and glucose standard (Figs. 3.2 - 3.4). This showed that the molecular weight of 
these extracts might be fallen into a smaller range when comparing with the 
standards. This might be due to the reason that the pore size of this column was 
relatively larger for the extracts components so that another column with a smaller 
pore size might give a better resolution in spreading out the peaks within extracts. 
In this way, another column, TSK gel G3000 PW, with a relatively smaller pore size 
was used for a better separation of extracts with lower molecular weight (Figs. 3.5 -
3.7). 
By doing so, peak separation for extracts using TSK gel G3000 PW column was 
improved, therefore, molecular weight of them was calculated more precisely and the 
signals from UV detector and RI detector were comparable (Figs. 3.5 - 3.7). 
There were two main peaks in the profile of PT-W from TSK G3000 column, 
with the average molecular weight of first peak to be about 29.5x1 O^  while that of 
another was about 10.3x10'^ (Fig. 3.5). The first peak with a higher molecular 
weight had a lower signal than the second peak with a lower molecular weight using 
the RI detection [Fig. 3.5 (a)], and at the same time, the latter peak had a much 
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stronger signal than the former one when using UV detection [Fig. 3.5 (b)]. This 
indicated that the peak with lower molecular weight might be consisted of protein 
residues with strong UV absorbance at 280mn. 
In the case of PC-W from TSK G3000 column, there were also two peaks in 
which the first one had a molecular weight of about 41.9x10'^ while that of the 
second one was about 1.5x10^ (Fig. 3.6). This time, the first peak, the one with a 
higher molecular weight, had a stronger signal as measured by the RI detector than 
the second one [Fig. 3.6 (a)]. However, the second peak, the one with a lower 
molecular weight, was found to have a stronger absorbance at 280nm [Fig. 3.6 (b)]. 
The profile of PR-W was comparable to that of PC-W in which the two peaks of 
PR-W were of similar range of molecular weight as that of PT-W. The molecular 
weight of the first peak as determined by TSK G3000 column was 45.6x1 O* and the 
other one was 1.4x10^ [Fig. 3.7 (a)]. Once again, the peak with a lower molecular 
weight had a stronger absorption of UV signal at 280nm than its higher molecular 
weight peak, indicating that the lower molecular weight peak might have a greater 
amount of protein present [Fig. 3.7 (b)]. 
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Table 3.6 A summary of SEC results of all three hot water extracts alone showing 
their molecular weight and relative proportion of the peaks 
Molecular weight 
Hot water extracts alone 
1 St peak 2nd peak 
PT-W 29.5 X 104 (19.0%)* 10.3 x 10^ (81.0%) 
PC-W 41.9 X 10^ (79.0%) 1.5 X 10^ (21.0%) 
PR-W 45.6 X 10^ (31.0%) 1.4x 10^ (69.0%) 




























































































































































































































































4,00- / S \ 
I T _ V Z 
0.00. A 十 A 
' ' ' ' I ' ' ' I ' ' ' > ' • ' I • • ' I ' ' • I ^ • I • ' ' I ' ' ' I ' ' ' I ' ' • I —— I 




i . s / « \ 
0.010- ts / \ 。 
0.0001 . . . • . . . • . • . 「 . . ， . . . ‘ . … ； ) 十 . . ， . . . ， . . . ， 
2.00 4.00 6.00 8.00 10.00 12.00 14.00 1 6.0) 18.00 20.00 22.00 24.00 26.00 28.00 30.00 
Mnutes 
Fig. 3.2 SEC profile of PT-W by TSK G5000 column using (a) RI detector and (b) UV detector. The 
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Fig. 3.3 SEC profile of PC-W by TSK G5000 column using (a) RI detector and (b) UV detector. The 
solvent used was 0.2M NaCl; flowrate at 0.5 ml/min and at 30°C. Positions of the pullulan standards 
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Fig. 3.4 SEC profile of PR-W by TSK G5000 column using (a) RI detector and (b) UV detector. The 
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Fig. 3.6 SEC profile of PC-W by TSK G3000 column using (a) RI detector and (b) UV detector. The 
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3.4.2 Charge distribution by ion exchange chromatography (lEC) 
Anion exchange column (lEC) was used for investigating the charge 
distribution of the mushroom sclerotial extracts. Both pullalan and pectin were 
used as neutral and charged standards, respectively. However, the lEC profile did 
not show a clear separation of peaks but rather a broad peak was observed for all 
mushroom extracts (data not shown), indicating that there had no neutral fractions 
present in the extracts. It also suggested that the protein in the extracts might bind 
to the polysaccharide as a charged complex. 
3.5 Antitumor effects of mushroom sclerotial extracts from hot water extraction 
alone 
3.5.1 In vitro antiproliferative study by HL-60 
HL-60 cells, suspension in nature, were one of the cell lines used for screening 
the antiproliferative effects of mushtoom sclerotial extracts from hot water extraction 
alone. PT-W showed an inhibitory effect of about 50% or above (Table 3.7). 
When the lowest concentration of hot water alone extracts (50// g/ml) was being 
considered, PT-W showed the weakest activity among the three extracts. PC-W 
also had a similar antiproliferative activity as PT-W in which they had about 50% 
growth inhibition on HL-60. PR-W had the best effect at 50 fi g/ml as it inhibited 
HL-60 growth more than 70% and it even showed an inhibition ratio of 87.1% at 200 
/ /g/ml (Table 3.7). 
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Table 3.7 Inhibition ratio (%) of mushroom sclerotial extracts from hot water 
extraction alone on HL-60 
Hot Water Extracts 
PT-W PC-W p ^ 
200 |j.g/ml 73.27 65.90 87.10 
100 |ig/ml 61.95 52.65 76.55 
50 )ig/ml 46.96 50.69 77.21 
3.5.2 In vitro antiproliferative study by MCF-7 
MCF-7 cell, adherent in nature, was another cell line used for assessing the 
antiproliferative effects of hot water extracts of mushroom. PT-W did not show 
significant inhibition on MCF-7 at all three concentrations tested. Similar to PT-W, 
PC-W also had no significant inhibitory effect on MCF-7. PR-W seemed to have 
even a proliferative effect on MCF-7 that was more obvious than PT-W and PC-W 
(Table 3.8). 
Table 3.8 Inhibition ratio (%) of mushroom sclerotial extracts from hot water 
extraction alone on MCF-7 
Hot Water Extracts 
PT-W PC-W PR-W 
200 |ig/ml ^ ^ ； 
100 [ig/ml 3.741 5.107 -
50 ^ig/ml -
*- means no growth inhibition observed 
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3.5.3 In vivo antitumor study by BALB/c mice 
Only two hot water extracts, PC-W and PR-W, were used for testing their in 
v/vo effects on Sarcoma S-180 grown on male BALB/c mice. Both fractions had an 
inhibition of SI80 growth on mice for over 50% at a concentration of 20 mg/kg, but 
PR-W exerted its inhibition on tumor growth more significantly (about 80%) than 
PC-W (Fig. 3.8). In addition, tumor regression was found in two out of ten mice 
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Fig. 3.8 In vivo antitumor effects of the two hot water extracts on Sarcoma S-180 
growing on BALB/c mice at 20 mg/kg. Data was analyzed by student's r-test and 
p<0.05 was considered to be significant. 
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3.6 Antitumor effects of extracts from sequential extraction scheme 
3.6.1 In vitro antiproliferative study by HL-60 
The native fractions of Pleurotus tuber-regium isolated by the sequential 
extraction scheme all showed a negative growth inhibition on HL-60 (Table 3.9). 
On the other hand, the corresponding carboxymethylated fractions of PT, although 
having a better water solubility, showed no significant growth inhibition on HL-60 
(Table 3.10). 
Among fractions obtained from the sequential extraction scheme, both 
PC-HWE and PC-CAE had stronger inhibition on HL-60 (Table 3.11). The 
carboxymethylated sonication fraction (CM-SON) (41.42%) of PC, showed an 
improvement of inhibitory effect when compared with the native counterpart 
(7.834%) at a concentration of 200 ^ig/ml (Table 3.11). 
In the case of Polyporus rhinocerus, the overall antiproliferative effects of all 
fractions were stronger than those from the other two mushrooms. PR-HWE was 
found to be most effective against the growth of HL-60 (over 30%) among the other 
native fractions from the sequential extraction scheme. However, after the 
improvement of water solubility by carboxymethylation, the sonication fraction 
(CM-SON) of PR had a stronger inhibitory effect on HL-60 at all concentrations than 
native SON fraction (Table 3.12). 
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Table 3.9 Inhibition ratio (%) of various native fractions from sequential extraction 
of Pleurotus tuber-regium on HL-60 
P. tuber-regium 
SON HWE CAE HAE 
200 lig/ml ]A29 - : ； 
100 iig/ml - . _ 
50 ^g/ml - 1.381 
*- means no growth inhibition observed 
Table 3.10 Inhibition ratio (%) of various carboxymethylated fractions of Pleurotus 
tuber-regium on HL-60 
Carboxymethylated P. tuber-regium 
CM-SON CM-HWE CM-CAE CM-HAE 
200 |ig/ml > ] J 4 3 - : 
100 |ag/ml 6.194 20.80 - 5.752 
50 l^g/ml - - - 8.840 
*- means no growth inhibition observed 
Table 3.11 Inhibition ratio (%) of various fractions from sequential extraction of 
Poria cocos on HL-60 
P. cocos 
SON CM-SON HWE CAE HAE 
200 |ig/ml 4 1 ^ 
100 iig/m\ 30.53 13.73 25.22 25.66 12.39 
50 \xg/m\ 28.31 18.56 22.10 22.51 12.98 
*- means no growth inhibition observed 
Table 3.12 Inhibition ratio (%) of various fractions from sequential extraction of 
Polyporus rhinocerus on HL-60 
P. rhinocerus 
SON CM-SON HWE C ^ HAE 
200 |ag/ml ^ 31.35 53.92 - 1 3 ^ 
100 |ag/ml 8.407 10.84 34.07 20.80 11.50 
50 Kig/ml 13.40 22.35 45.72 29.56 21.69 
*- means no growth inhibition observed 
77 
3.6.2 In vitro antiproliferative study by MCF-7 
The adherent MCF-7 cells were used as another cell line for screening the 
biological activities of various fractions from sequential extraction scheme. Similar 
to the samples from hot water extraction alone (Table 3.8)，all fractions from 
sequential extraction scheme of the three mushroom sclerotia had no significant 
inhibition on the growth of MCF-7 (Table 3.13-3.16). 
In general, all native fractions of PT did not have any significant inhibitory 
effect on MCF-7 (Table 3.13) and the carboxymethylated fractions did not improve 
the inhibition on the growth of MCF-7 (Table 3.14). 
Both CAE and HAE of PR had a relatively stronger inhibition on MCF-7 than 
other fractions obtained from the sequential extraction scheme, but, the inhibition 
was not statistically significant (Table 3.16). HAE of PC showed a relatively higher 
inhibitory effect than other fractions (Table 3.15) but the effect was not significant. 
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Table 3.13 Inhibition ratio (%) of various native fractions from sequential extraction 
of Pleurotus tuber-regium on MCF-7 
P. tuber-regium 
SON HWE CAE HAE 
200 i^g/ml ^ - - L ^ 
100 [ig/ml - - 15.40 2.021 
50 |ig/ml 11.13 - - -
* - means no growth inhibition observed 
Table 3.14 Inhibition ratio (%) of various carboxymethylated fractions of Pleurotus 
tuber-regium on MCF-7 
Carboxymethylated P. tuber-regium 
CM-SON CM-HWE CM-CAE CM-HAE 
200 i^g/ml ^ I : ； 
100 )ig/ml -
50 p-g/ml -
* - means no growth inhibition observed 
Table 3.15 Inhibition ratio (%) of various native fractions from sequential extraction 
of Poria cocos on MCF-7 
P. cocos 
SON HWE CAE HAE — 
200 |ig/ml ^ - -
100 i^g/ml 4.315 - 13.08 8.001 
50 |ig/ml - - 22.67 
* - means no growth inhibition observed 
Table 3.16 Inhibition ratio (%) of various native fractions from sequential extraction 
of Polyporus rhinocerus on MCF-7 
P. rhinocerus 
SON HWE ^ HAE 
200 |ig/ml -* 4.082 29.50 17.94 
100 |ig/ml 12.64 - 4.888 4.997 
50 ^ig/ml - - 13.38 
* - means no growth inhibition observed 
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3.6.3 In vivo antitumor study by BALB/c mice 
Only HWE of PT showed an inhibition of SI 80 on male BALB/c mice for about 
50% but other fractions had a negative inhibitory effect on the tumor growth (Fig. 
3.9). However, the injection of PC extracts showed that only CAE and HAE had 
growth inhibition on SI80 no more than 10% and other fractions, particularly, HWE 
had a proliferative effect on tumor growth (Fig. 3.10). All native fractions of PR, 
together with its carboxymethylated fraction, showed a significant (p<0.05) 
inhibition of tumor growth on BALB/c mice ranging from 43.72% to 79.41% (Fig. 丨 
3.11). 
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Fig. 3.9 In vivo antitumor effects of various fractions of Pleurotus tuber-regium on 
Sarcoma S-180 growing on male BALB/c mice at dose of 20 mg/kg. Data was 
analyzed by student's r-test and /?<0.05 was considered to be significant. 
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Fig. 3.10 In vivo antitumor effects of various fractions of Poria cocos on Sarcoma 
S-180 growing on male BALB/c mice at dose of 20 mg/kg. Data was analyzed by 
student's /-test and p<0.05 was considered to be significant. 
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Fig. 3.11 In vivo antitumor effects of various fractions of Polyporus rhinocerus on 
Sarcoma S-180 growing on male BALB/c mice at a dose of 20 mg/kg. Data was 
analyzed by student's f-test and p<0.05 was considered to be significant. 
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3.7 Comparison of in vitro and in vivo activities of mushroom sclerotial extracts 
Although PT-W had growth inhibition on HL-60 cells (Table 3.7), all its fractions 
from sequential extraction showed no inhibitory effects on HL-60 (Table 3.9). All 
the carboxymethylated fractions of PT from sequential extraction scheme had better 
water solubility but only improved the antiproliferative activity of hot water extracts 
(HWE) (Table 3.9) and the inhibition of HL-60 was no more than 20% (Table 3.9 
and 3.10). It was reported previously that hot alkali extracts of PR with a molecular 
range of (5.8-17.1) x lO* had an inhibition of HL-60 by 10 to 44.5%, and those with 
a higher or lower molecular weights showed only slight or no inhibition on the 
growth (Zhang et al., 2001). The hot alkali extracts (HAE) from PT in this project 
showed no significant growth inhibition on HL-60 (Table 3.9) and this might be due 
to the different approach adopted to obtain the hot alkali extract. The HAE in this 
project was obtained by boiling IM NaOH after a sequential extraction of sonication, 
hot water extraction and cold alkali extraction; and the hot alkali extraction from 
Zhang and colleagues was carried out by boiling the sclerotium at 120�C with 0.5M 
NaOH after the washing with ethyl acetate, acetone, 0.9% sodium chloride and cold 
dilute alkali solution (Zhang et a l , 2001). The hot alkali extracts from these two 
methods might differ at their molecular weights and conformations because of the 
different extent of degradation during the extraction which resulted in different 
biological activity on HL-60. 
The overall in vitro antiproliferative effect of PC-W on HL-60 by extracts from 
sequential extraction scheme was better than that of PT. The hot water extracts 
from sequential extraction scheme (Table 3.11) did not have the antiproliferative 
effect on HL-60 as potent as that o f P C W (Table 3.7). Culturing medium of human 
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peripheral blood mononuclear cells (MNC) incubated with PC polysaccharides was 
found to be effective in inhibiting the growth of HL-60 by more than 70% (Chen and 
Chang, 2004). This was an ex vivo assay in which PC cold water extracts was 
incubated with human MNC, so that the inhibitory effect on HL-60 was greatly 
improved through a immunostimulatory response. However, the different PC 
fractions obtained in the present study was added directly to see if there was any 
antiproliferative effects on HL-60 rather than a host mediatory effect. 
The hot water extract from sequential extraction scheme of PR showed a 
relatively higher inhibition ratio of HL-60 then all other fractions from sonication, 
cold and hot alkali extractions (Table 3.12), but still, the effect from PR-W was the 
best among all PR fractions (Table 3.7). At the concentration of 200 ji g/ml, HWE 
of PR showed an antiproliferative effect on HL-60 of about 50% (Table 3.12)，but the 
same effect was seen in PR-W at a concentration of much lower than 50 i^g/ml (Table 
3.7). 
Therefore, the fractions from sequential extraction scheme of PC and PR were 
generally found to have a better growth inhibition on HL-60 cells (Table 3.11 and 
3.12) and PR-W had the best inhibitory effect on HL-60 among the three hot water 
extracts (Table 3.7). 
Since the inhibition on cell line in vitro was based on specific cytotoxic effects of 
the different mushroom sclerotial extracts, in vivo assay was necessary to be carried 
out to determine whether there were any host-mediated effects exerted by them. All 
fractions from PC and PR were tested in vivo on male BALB/c mice and fractions of 
PT from sequential extraction scheme except PT-W were chosen for in vivo assay. 
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PC-W and PR-W were chosen because their fractions from sequential extraction 
scheme also showed better in vitro in inhibition on the growth of HL-60. 
Both PC-W and PR-W showed inhibition of solid tumor, SI80, grown on male 
B A L B / C mice (Fig. 3.8) in which the antitumor effect of PR-W was found to be 
potent and tumor regression was observed (2 out of 10 mice). For the fractions of 
PT，hot water extract (HWE) was the only fraction shown to have growth inhibition 
on S180 by 50% (Fig. 3.9). The antitumor effect of PT-HAE was lower than that of 
a hot alkali extract of PT reported previously (76%) (Zhang et al., 2001). As 
mentioned before, this difference could be due to the different extraction conditions 
used to obtain the hot alkali extracts so that their biological actions varied. In the 
case of PC, only its CAE and HAE fractions had a slight growth inhibition on SI 80 
//? vivo (Fig. 3.10). The other fractions did not show any inhibitory effects and thus, 
the overall inhibitory effect of PC fractions on SI 80 was comparatively weaker than 
the other 2 sclerotial extracts (Fig. 3.10). After obtaining the results from in vitro 
assay of all fractions and the in vivo assay of hot water extracts, PR had the best 
performance when compared with the other two mushroom sclerotia. As PR-W had 
a strong inhibition of SI80 in vivo (Fig. 3.8)，all its other fractions were also tested 
for their in vivo inhibition on SI80 (Fig. 3.11). It turned out that all PR fractions 
had more potent inhibitory effect and this phenomenon was not observed in the other 
two mushroom sclerotia (Fig. 3.9-3.11). 
In addition, fractions added at a concentration from 50 ji g/ml to 200 ji g/ml 
were found to have no cytotoxic effects on normal monkey cell lines (VERO) (data 
not shown). 
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3.8 Dose-response relationship of hot water extract from PR on cancer cell lines 
3.8.1 In vitro dose-response antiproliferation of PR-W and PR-HWE on HL-60 
As mentioned above, PR-W and PR-HWE had more potent antiproliferative 
effect on HL-60 than MCF-7 among all fractions (Figs. 3.4，3.5 and 3.11) and were 
therefore chosen for further study. Among all extracts from the three mushrooms, 
PR showed a potent effect on inhibiting the growth of HL-60, in particular the 
PR-HWE and PR-W fractions (Fig. 3.4). 
Six concentrations of mushroom sclerotial extracts were prepared to further 
study the dose-response relationship between these concentrations and growth 
inhibition on HL-60 cells. In general, both PR-HWE and PR-W showed an increase 
in the inhibition on HL-60 with an increase in the concentration of the extracts (Table 
3.17). PR-HWE had significant (p<0.05) inhibition on HL-60 cells starting at a 
concentration of 50 |ag/ml while that of PR-W was found to be at a concentration of 
100 (ig/ml. However, dose-response of inhibition of HL-60 (50.21% to 96.60%) by 
PR-W was generally higher than that of PR-HWE (26.77% to 62.37%) (Table 3.17). 
At the concentration of 300/zg/ml, PR-HWE showed an antiproliferative effect on 
HL-60 of about 50% (Fig. 3.13), but the same effect was seen in PR-W at a 
concentration of only about 100 |ig/ml (Fig. 3.12). Therefore, PR-W was shown to 




Table 3.17 /« vitro dose-response relationship of HL-60 by two hot water extracts 
from Polyporus rhinocerus 
P. rhinocerus 
PR-W HWE 
400 |ig/ml 96.60 62.37 
P value <0.001 <0.001 
200 |ig/ml 67.66 40.12 
P value <0.001 <0.001 
100 I^g/ml 50.21 32.43 
P value 0.001 <0.001 
50 ng/ml 11.49 26.77 
P value 0.250 <0.001 
25 )ig/ml 10.21 5.73 
P value 0.334 0.381 
12.5 i^g/ml 8.085 16.25 
P value 0.477 0.283 
Data was analyzed by student's /-test and p<0.05 was considered to be significant. 
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Fig. 3.12 Dose-response relationship of PR-W of Polyporus rhinocerus on HL-60 
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Fig. 3.13 Dose-response relationship ofPR-HWE of Polyporus rhinocerus on HL-60 
Therefore, when combining the in vitro and in vivo results, all the hot water 
extracts - PT-W, PC-W and PR-W had potent antitumor effects. For all the 
fractions from sequential extraction scheme, only PR-HWE showed a potent in vitro 
inhibition on HL-60 while PR-W had the most potent effect in both in vitro and in 
Ww assays. The concentration of PR-W needed to inhibit the growth of HL-60 was 
generally lower than PR-HWE (Table 3.17), PRW was a potent antitumor agent that 
was worthy of further evaluation. 
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3.8.2 In vitro dose-response antiproliferation of PR-W on K562 and S180 
PR-W was determined to be the most effective fraction against the growth of 
HL-60 cells among all fractions from the three mushroom sclerotia. This fraction 
was selected for further evaluation of its antitumor effect on other cancer cell lines. 
One adherent cell line, HepG2 and two suspension cell lines, K562 and SI80 were 
used for testing the antiproliferative effects of PR-W. PR-W did not have any 
inhibition on HepG2 (data not shown) at the six concentrations used in 3.8.1 but the 
antiproliferative effects on K562 and SI80 were significant (Figs. 3.14 and 3.15). 
After plotting the histogram showing the dose-response relationship, it was obvious 
from the overall pattern that PR-W had a more potent effect on SI80 (Fig. 3.15) than 
K562 (Fig. 3.14). Therefore, PR-W was shown to be more effective in inhibiting 
the growth of SI 80 cells, followed by K562 and HL-60 cells. 
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Fig. 3.14 In vitro dose-response relationship of K562 by PR-W. Data was analyzed 
by student's /-test and /7<0.05 was considered to be significant. 
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Fig. 3.15 In vitro dose-response relationship of SI 80 by PR-W. Data was analyzed by 
student's ,-test and；7<0.05 was considered to be significant. 
When the in vitro assays were carried out, it was suspected that PR-W was 
effective against cell lines of the suspension type but not of adherent type, as its 
response towards HL-60 and MCF-7 had a great difference. To prove this point, 
more cell lines were employed to test for this hypothesis of whether PR-W was 
specifically effective towards suspension cell lines. HepG2 was chosen because it 
was another kind of adherent cell commonly used for in vitro study in antitumor 
research (Zhang et al., 2001). Since the in vivo growth inhibition of S180 by PR-W 
was promising, it was necessary to examine if a different pathway other than 
host-mediation existed. Therefore, SI80 was used for the in vitro study to see if 
PR-W also had direct cytotoxic effect. Since PR-W was effective in inhibiting the 
growth of HL-60, another leukemic cell line, K562, was chosen to observe the effects 
of PR-W on acute (HL-60) and chronic (K562) leukemia, respectively. 
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As expected, there was no growth inhibition on HepG2 by PR-W but significant 
inhibitory effect was observed on both SI80 and K562 cells. SI80 was a murine 
sohd tumor cell line and its growth was suppressed more than 20%by PR-W even at 
the lowest concentration used (12.5 ^ig/ml). PR-W also had a significant growth 
inhibition on K562 (Fig. 3.14), but the overall pattern of growth inhibition by PR-W 
on HL-60 was more significant than that of K562 (Figs. 3.12 and 3.14). It seemed 
that the chronic leukemic cells were more resistant to PRW than the acute ones and 
this might be related to the genetic makeup of this chronic leukemic cell. The 
feature of this cell was the presence of the Philadelphia chromosome (Ph), which was 
originated from a reciprocal translocation between chromosomes 9 and 22 (Nowell 
and Hungerford, 1960; Rowley, 1973). This caused a head-to-tail fusion of the 
breakpoint cluster region (BCR) gene on chromosome 22 with the cellular 
homologue of the Abelson (c-ABL) viral oncogene on chromosome 9 and resulted in 
the fused BCR-ABL oncogenes (Heisterkamp et al., 1985). This kind of gene 
translocation was found to be one of the causes of the drug resistance found in K562 
as this cell line was resistant to many kinds of anticancer drugs (McGahon et al., 
1994). Since the effect of PRW in our project was most effective in inhibiting the 
growth on SI80 and least effective against K562, it was consistent with the previous 
studies on K562 cells that they were resistant to drugs. In addition, K562 cell is 
originated from human while SI80 is from mice, K562 has drawn more research 
interest. 
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3.8.3 In vivo dose-response relationship of PR-W on S180 
The biological activities of PR-W were further tested by setting a dose-response 
relationship to find out the most effective concentration for inhibiting the growth of 
SI80 in BALB/c mice. There was no significant growth inhibition on SI80 by the 
PR-W (Table 3.18). Although a better growth inhibition was found at 5 mg/kg, a 
trend of dose-response relationship of PR-W was not observed. This result was not 
even comparable to the previous in vivo assay of PR-W on SI80 grown on male 
BALB/c mice because the tumors were infiltrating on the mice in all groups and an 
accurate comparison of tumor reduction between PR-W-treated groups and control 
group was not possible. 
Table 3.18/;? vivo effects of different doses of PR-W on SI 80 growing on BALB/c 
mice 
R rhinocerus (mg/kg) 
5 10 20 40 
inhibition% 37.91 ^ -* 17.92 
* - means no growth inhibition observed 
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3.9 Flow cytometric analysis ofPR-W on cancer cell lines 
3.9.1 Antiproliferative effect ofPR-W on HL-60 
A concentration of 200 ^ig/ml was chosen for PR-W for flow cytometry because 
this concentration inhibited about 50% growth of HL-60 as shown in our previous 
results (section 3.8.1). The sub-Gi peak was regarded as apoptotic peak [Fig. 3.16 
(b)，（d) & (f)]，followed by the G � ， S and G2/M peaks. For a 24-hour incubation 
with PR-W, there was already a significant increase of sub-Gi peak (33.85%) 
comparing with the control group [Fig. 3.16 (a) & (b)]. After a 48-hour incubation 
period, both sub-G, (55.95%) and G, (70.10%) peaks were significantly (p<0.05) 
higher than the control group [Fig. 3.16 (c) & (d)]. In addition, the S (21.30%) and 
G2 (8.53%) phases had a significantly lower % of cells in the PR-W treatment group 
(Table 3.19). When it finally came to the end of a 72-hour incubation [Fig. 3.16(e) 
& (f)]，the majority of cells were present in the sub-Gi peak (77.75%) and G丨 peak 
(85.30%) while the S (0.50%) and G2 (14.13%) peaks were significantly reduced 
(Table 3.19). The percentage of cells of both sub-Gi and Gi peaks gradually 
increased during incubation from 24 hours to 72 hours, which was an indication of 
apoptosis being taken place. 
HL-60 was known to have mutation so that the p53 gene deleted (Wolf and 
Rotter, 1985) and was recognized as p53-null. Therefore, the role of p53 was lost in 
HL-60 cells, resulting in a loss of apoptotic function (Vousden and Lu, 2002). 
Surprisingly, apoptosis took place in HL-60 when PR-W was added at a 
concentration of 200 |Lig/ml, indicating that apoptosis occurred due to the regulation 
of other cell cycle proteins. The percentage of cells incubated with PR-W in sub-Gi 
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and G, phases increased (Table 3.19) significantly, while that of control did not show 
significant changes in these two phases. In response to the accumulation of cells in 
these two phases, there was a decrease in percentage of cells in both S and G2 phases; 
and particularly, there was a sharp decrease of percentage of cells in S phase at 
7 2-hour incubation so that almost no cells passed the G� phase checkpoints and enter 
this phase (Fig. 3.16). Therefore, Gi arrest was obviously induced by PR-W on 
HL-60 cells after 24, 48 to 72-hour incubation that eventually caused apoptosis. 
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Fig. 3.16 DNA histograms showing the effect of PR-W on the cell cycle of HL-60 
cells. The HL-60 cells were incubated with 200 |ig/ml PR-W for (b) 24 hours, (d) 48 
hours and (f) 72 hours, respectively, comparing to their controls (a, c and e). 
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Table 3.19 Numeric data showing the proportion of HL-60 cells in different cell 
cycle phases by PR-W (200 昭/ml) 
Apoptotic cells Non-apoptotic cells 
Treatment 
(Sub-Gi) Go/Gi S G2/M 
24h-control 11.4 49.5 36.1 14.4 
24-PR-W 33.9* 53.9* 29.7 16.4 
48-control 9.46 52.8 31.3 15.9 
48-PR-W 56.0*** 7 0 . 1 " 21.3** 8.53** 
72-control 17.8 48.5 32.4 19.0 
72-PR-W 77.8*** 85.3*** 0.50*** 14.1 
Results were compared by student's /-test in which * indicated forp<0.05，** forpO.Ol and *** for 
p<0.00l 
3.9.2 Antiproliferative effect of PR-W on K562 
K562 was another human cell line selected for checking its cell cycle profile 
with the addition of PR-W. This cell line was chosen due to the reason that the 
growth of both K562 and SI80 cells was inhibited by PR-W, however, SI80 was a 
murine cell line. It was more preferable to choose a human cell line for comparison 
with the human acute leukemia (HL-60) cells. The concentration of 400 jig/ml for 
PR-W was chosen for flow cytometry because it inhibited about 50% growth of 
K562 as shown in our previous results (section 3.8.2). In general, there was a trend 
that the percentage of cells of sub-Gi peak increased from 24-hour to 72-hour 
incubation (Fig. 3.17). This increase was insignificant as analyzed by statistical 
methods and the percentage of cells from other phases of the cell cycle did not show 
a significant change when compared with the control at 24，48 and 72-hour 
incubatory period (Table 3.20). 
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Although there was a slight increase in the percentage of K562 cells with sub-Gl 
peak (Table 3.20), apoptosis did not take place as no specific cell cycle arrest had 
been observed (Fig.3.17). This was consistent with previous findings that HL-60 
was apoptosis-proficient in which it readily underwent apoptosis with the addition of 
various kinds of chemotherapeutic agents (Kaufmann, 1989). When compared with 
HL-60, K562 seemed to be quite apoptosis-resistant towards many stimuli due to the 
presence of bcr-abl gene (McGahon et al., 1994) and developed resistance 
particularly to drug-induced apoptosis (Bedi et al., 1995). It was known that 
whether there was cell cycle arrest by cells was due to the drug sensitivity to the cells 
(Dubrez et al., 1995). More and more researches indicated that bcr/abl gene 
exerted its anti-apoptotic effect by blocking the mitochondrial release of cytochrome 
c and activation of caspase-3，which were the molecular bases of the delayed 
response of K562 cells that caused downstream of bcl-2 phosphorylation 
(Amarante-Mendes et al., 1998; Gangemi，2000). When docetaxel, an anti-mitotic 
agent developed for treating leukemia, was added to HL-60 and K562 cells, there 
was a delayed apoptotic response of K562 cells (DNA fragmentation observed after 
24 hours) compared to HL-60 cells (DNA fragmentation observed within 6 hours) 
(Cao et a l , 2004). Such drug-resistant and apoptosis-resistant characters of K562 
matched with the results in this project in which the concentration of PR-W in 
inhibiting the growth of HL-60 was generally lower than that of K562, and the 
apoptotic response was not significant when compared to HL-60 cells. 
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(e) 72-hour control (f) 72-hour PR-W 
Fig. 3.17 DNA histograms showing the effect of PR-W on the cell cycle ofK562 
cells. The HL-60 cells were incubated with 400 ng/ml PR-W for (b) 24 hours, (d) 48 
hours and (f) 72 hours, respectively, comparing to their controls (a, c and e). 
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Table 3.20 Numeric data showing the proportion of K562 cells in different cell cycle 
phases by PR-W (400 |ig/ml) 
Apoptotic cells Non-apoptotic cells 
Treatment — 
(Sub-Gi) Go/G, S G2/M 
24h-control 5.22 28.7 50.8 20.6 
24-PR-W 16.7 26.5 52.4 21.1 
48-control 2.47 26.0 53.7 20.3 
48-PR-W 7.64 29.5 51.7 18.8 
72-control 2.25 28.5 52.6 19.0 
72-PR-W 14.0 27.3 53.1 19.6 
3.9.3 Proposed mechanisms of cell cycle arrest by PR-W 
It was normal that these two cell lines, HL-60 and K562 (although apoptosis was 
not significantly demonstrated in my experiment) were arrested at different phases in 
order for apoptosis to take place since their sensitivities to drugs and resistances to 
apoptosis were different. One of the examples using docetaxel illustrated that 
HL-60 cells were arrested at Gi phase while K562 cells were arrested at G2/M phase 
(Cao et al., 2004). This also matched with the aforementioned occurrence of DNA 
fragmentation in which an earlier fragmentation indicated an arrest at the beginning 
of cell cycle while a later one indicated an arrest near the end of cell cycle (Cao et al.， 
2004). 
It was clear from the flow cytometric analysis that HL-60 cells were being 
arrested by PR-W at Gi phase but the genes involved were not yet determined. 
These genes might become the targets of PR-W to act on and induced apoptosis in 
98 
HL-60 cells. Since HL-60 cells were p53-null, restoration of p53 function was not 
responsible for their apoptosis. For example, HL-60 cells were also induced to have 
Gi arrest by esculetin, a coumarin derivative from many plants as folk medicines 
(Chang et al., 1996). There was a down-regulation of cyclins D1 and E, which were 
important for regulating the cell to pass through Gi checkpoint. Also, there was an 
up-regulation of p27 and reduced expression of Cdk4 that inhibited the 
phosphorylation of Rb protein so that the cell cycle progression was inhibited (Wang 
et a l , 2002). 
In this experiment, though the apoptosis of K562 was not demonstrated by PR-W 
as no cell cycle arrest was shown, there were few proposed mechanisms of how the 
cell cycle of K562 was regulated that led to apoptosis. To investigate the 
mechanism of apoptosis in K562 cells, it was necessary to understand how the arrest 
of cell cycle was inhibited for cells with the presence of bcr-abl gene. Unlike the 
HL-60 cells that have Gi arrest exerted by PR-W, it was proposed in other literatures 
that the bcr-abl gene presence would inhibit apoptosis, for example in the case of 
K562 cells. It was generally suggested that the inhibition of its apoptosis involved 
those proteins that regulated the cell cycle at G2/M phase because apoptosis was 
demonstrated to be delayed when the transit of irradiated murine haemopoietic cells 
through G2 was prevented (Collins et a l , 1992; Bedi et al., 1995). It was reasonable 
to speculate that in order to have apoptosis to be occurred in K562, a cell cycle arrest 
at G2 phase was crucial. The passage of G2 to M phase involved the regulation by 
cdkl by which it had to bind to cyclin B, and if the entry to M phase was delayed, 
there was more time for the repair of DNA damage in G2 phase and apoptosis was 
delayed and even not taking place (Liu et al., 2002). There was no significant 
apoptotic peak in K562 observed in our study might be due to the reason that the 
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concentration of PR-W added was not high enough to induce apoptosis in K562 as 
compared to that in HL-60 cells. The concentration of PR-W used to induce 
apoptosis in both HL-60 and K562 cells was the one that had only about 50% growth 
inhibition. By increasing this concentration of PR-W added to K562 cells, 
apoptosis of the cells might be observed. 
3.10 Host-mediated antitumor mechanism of PR-W 
3.10.1 Mouse cytokine array 
Serum drawn from mouse injected with 5 mg/kg or 50 mg/kg of PR-W with and 
without S-180 tumor implantation and with and without the injection of LPS was 
used for cytokine array (Table 3.21) and the results are shown below (Fig. 3.18). 
The array for mouse with tumor is not shown because the expression profile of 
cytokine of both treatment and control group was the same. No reduction or 
increase of all cytokines was observed when compared with the control under this 
condition (with tumor implantation) for the above two doses of PR-W (data not 
shown). For those mice injected with LPS, the level of cytokine signals was too 
high even with dilution (lOOX dilution). Therefore, only serum without tumor and 
LPS could give differential signals of cytokines that were expressed in mouse serum 
(Fig. 3.18). 
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Table 3.21 RayBio® Mouse Cytokine Antibody Array 
A B C D E F G H I J K L 
1 Pos Pos Neg Neg 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL-4 
2 Pos Pos Neg Neg 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL-4 
3 IL-5 IL-6 IL-9 EL-IO IL-12 IL-I2p70 i f t i S EL-17 IFN-y. KC Leptm MCP-1 
—— . . . . . � . ； ;、 ..I 二 、 、 . ： -
4 IL-5 IL-6 IL-9 IL-10 IL-12 IL-12p70 IL-U IL-17 IFN-7 KC Leptin,MCP-1 
STNF 
5 MCP-5 MlP-la MIP-2 MIP-3p RANTES SCF TARC TIMP-1 TNF-a Tpo VEGF 
R1 
STNF 
6 MCP-5 MlP-la MIP-2 MIP-3P RANTES SCF TARC TIMP-1 TNF-a Tpo VEGF 
R1 
7 Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Pos 
^ ^ 
8 Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank rBlank Pos 
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Fig. 3.18.Cytokine array of mouse serum drawn without tumor implantation, without 
injection of LPS and with (a) 50 mg/kg PR-W and (b) 5 mg/kg PR-W injected 
intraperitoneally for ten consecutive days. Cytokines and chemokines that have 
differential expression are labelled in (a). 
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Twenty-five cytokines and chemokines were found to have differential 
expression in the serum of mice treated with PR-W (Fig. 3.18) as shown in the 
cytokine antibody array. Among these cytokines and chemokines, more than fifteen 
of them were found to have a higher expression as observed (Fig. 3.18). These 
cytokines acted differently on effector cells so that different mechanisms were 
carried out to have immunomodulatory effects on the host. CTACK was the short 
form of cuteaneous T-cell attracting chemokine and GCSF referred to granulocyte 
colony stimulating factor that acted as a growth, differentiating and activating factor 
for neutrophils, it could synergize with IL-3 to stimulate growth of haematopoietic 
progenitors, and causes proliferation and migration of endothelial cells. GM-CSF, 
granulocyte/macrophage colony stimulating factor, was a survival and growth factor 
for haematopoietic progenitor cells, endothelial cells, erythroid cells, 
megakaryocytes and T cells, and a differentiating and activating factor for 
granulocytic and monocytic cells. IL-2, interleukin 2’ could stimulate the growth 
and differentiation of T cells, B cells, NK cells, LAK cells, monocytes, macrophages 
and oligodendrocytes. IL-3, interleukin 3，was a haematopoitetic growth factor 
stimulated colony formation of erythroid, megakaryocyte, neutrophil, eosinophil, 
basophil, mast cell and monocytic lineages and a growth factor for B lymphocytes, 
its activity would be enhanced when co-stimulated with other cytokines. IL-4, 
interleukin 4, was secreted by T cells and mast cells, and it induced the secretion of 
IgGl and IgE by mouse B cells and IgG4 and IgE by human B cells and this isotype 
switching property was shared with IL-13. IL-5, interleukin 5, was a T-cell derived 
glycoprotein that stimulated the colony formation of eosinophil, however, this was a 
growth and differentiation factor for mouse B cells only but not in human. IL-6, 
interleukin 6, was a multifunctional cytokine secreted by both lymphoid and 
non-lymphoid cells which regulated B and T cell function, haematopoiesis and acute 
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phase reactions. IL-9，interleukin 9，enhanced proliferation of T lymphocytes, mast 
cell lines, megakaryoblastic leukaemia cell lines and erythroid precursors. IL-10， 
interleukin 10，stimulated and/or enhanced proliferation of B cells, thymocytes and 
mast cells, it also cooperated with transforming growth factor (TGF)-P to stimulate 
IgA production by human B cells. IL-13, interleukin 13，was secreted by activated 
T cells and it inhibited the production of lL- ip , TNF-a and IL-8. IL-17, interleukin 
17，was secreted by CD4+ T lymphocytes and can cause the mobilization of 
neutrophils. IFN-y, interferon-y, was a cytokine involved in the regulation of nearly 
all phases of immune and inflammatory responses that included activation, growth 
and differentiation of T cells, B cells, macrophages, NK cells and other cell types 
like endothelial cells and fibroblasts (Callard and Gearing, 1994). 
There were many other chemokines being expressed, like KC (murine KC), 
MCP-5 (monocyte chemoattractant protein), MlP-la (macrophage inflammatory 
protein-la), MIP-2 (macrophage inflammatory protein 2), MIP-3p (macrophage 
inflammatory protein-3P), RANTES (regulated upon activation, normal T-cell 
expressed and secreted), STNF RI, TARC (thymus- and activation-regulated 
chemokine) and Tpo (thymopoietin). 
The interactions of interleukins expressed in serum after the injection of PR-W 
in male BALB/c mice were summarized in figure 3.19. There are two 
subpopulations for T helper cells according to different kinds of cytokines they 
secreted upon stimulation. The Thl subset secretes IL-2, IL-3, IFN-y and TNF-P 
while the Th2 subset secretes IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13 and GM-CSF 
(Parronchi et a l , 1991; Romagnani，1991; Zurawski and de Vries, 1994). The 
expression pattern of mouse serum showed that the Th2 subset of T cells was mainly 
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stimulated to enhance humoral antibody-mediated immune response (Carter and 
Dutton, 1996)，and IL-4, IL-5 and IL-6 functioned as assisting in B cell activation. 
On the other hand, the presence of IL-10 suppressed the cytokine production by the 
Thl subset that caused the reducing secretion of IL-2, IFN-y and TNF (Goldsby et al., 
2000). 
3.10.2 Quantification of IL-13 by ELISA 
Eight healthy normal mice were treated individually with intraperitoneal 
injection of PR-W at 50 or 5 mg/kg body weight and their serum was drawn for 
quantifying the IL-13 level using ELISA. For another set of mice injected both 
with LPS and PR-W, their serum was pooled together for the following IL-13 
measurement. Due to a wide range of response of individual mouse, the % increase 
of IL-13 of mice injected with 5 mg/kg PR-W without LPS priming action ranged 
from 11.52 to 153.7 comparing with the control while that for 50 mg/kg PR-W was 
found to be ranging from 28 to 251.1. On the other hand, the response of mice 
injected with both LPS and PR-W showed a lower % increase of IL-13 (Table 3.22). 
Among all the cytokines and chemokines, IL-13 had the highest expression. 
IL-13 was well known to induce airway hyperresponsiveness and allergic 
inflammations (Grunig et al., 1998). IL-13 was usually expressed with IL-4 as they 
had similar activity and the genes encoding them were closely linked on human 
chromosome 5 and mouse chromosome 11 (McKenzie et al., 1993), but it was 
recently found that IL-13 was not always co-expressed with IL-4 in normal T cells 
(Kishikawa et al., 2001) that matched with the study in this project. It was also 
surprising that TNF-a was not expressed in the mouse serum. This might be related 
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to the presence of IL-13 that repressed TNF-a expression. This was because TNF-a 
was always secreted whenever there was inflammation and immune response being 
induced. In this situation, this was related to the high expression of IL-13 because 
this cytokine would inhibit the expression of many other inflammatory cytokines, 
especially, TNF-a (Callard and Gearing, 1994). TNF-a was particularly induced by 
the injection of LPS (Ohno et al., 1995)，but the serum from the mice injected with 
LPS also showed no expression of it (data not shown). 
The expression of IL-13 in mouse serum was the strongest in the mice without 
tumor implantation and LPS injection. Since individual mouse was used, it was 
normal to have different immune response from different mice so that a range of 
IL-13 was measured in groups with different concentrations of PR-W injected. One 
of the key features of natural killer T (NKT) cells was the release of IL-13 after 
antigen stimulation (Matsuda et a l , 2003; Stetson et al., 2003). When the mast cells 
were activated, Th2-associated cytokines like IL-3, IL-4, IL-5 and GM-CSF were 
released, but IL-13 was also produced and played an important part in stimulating 
IgE expression (Emson et al., 1998). Therefore, the high amount of IL-13 in this 
project might be due to different effector cells being activated. 
106 
Table 3.22 Percentage increase of IL-13 on mice injected with PR-W with and 
without LPS (5 mg/kg and 50 mg/kg) 











-Numbers in bold type are identification number of individual mouse 
* Mice injected with PR-W only were assessed as individual and serum was not 
pooled together for IL-13 determination 
** Mice injected with both PR-W and LPS were assessed as a group and sera were 
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3.10.3 Immunostimulatory effects of PR-W on mice 
BALB/c mice without tumor implantation were injected with PR-W at dose of 
50 and 5 mg/kg body weight (withour the addition of LPS). At termination, the 
number of splenocytes and peritoneal cells isolated from the animals were counted 
separately into suspension and adherent subtypes. Although there was cell 
proliferation when compared with the control, this increase was of no statistical 
significance (Table 3.23). It was observed that mice injected with 5 mg/kg PR-W 
had a higher splenocyte proliferation, but the mice injected with 50 mg/kg PR-W 
had a higher peritoneal cell proliferation (Table 3.23). 
In addition, when the spleens were removed, it was found that the size of 
spleens was larger for the mice injected with higher dose of PR-W. Therefore, the 
weight of spleens with the injection of PR-W was significantly increased. The 
spleens of mice injected with 50 mg/kg had a significant increase of weight by 
181.6% while those injected with 5 mg/kg had a significant increase of weight by 
56.38% (Table 3.24). 
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Table 3.23 Cell count of splenocyte and peritoneal exucate cells of BALB/c mice 
treated with PR-W (5 mg/kg and 50 mg/kg body weight) without tumor implantation 
Number of cells % of proliferation p value 
Splenocyte-suspension 
PR-W-50 142士33 x 10^ 0.155 
PR-W-5 178 土46 x 105 0.098 
Splenocyte-adherent 
PR-W-50 25士 14x 105 0.208 
PR-W-5 59土6.2\105 0.002 
Peritoneal-suspension 
PR-W-50 44士44 x 105 90.63 0.571 ~ 
PR-W-5 39±36x 10^ 0.593 
Peritoneal-adherent 
PR-W-50 20土 11 X 105 0.358 
PR-W-5 18jrl2x 10' 68.99 0.484 
Data was analyzed by student's r-test and p<0.05 was considered to be significant. 
Table 3.24 Weight of spleens of BALB/c mice treated with PR-W (5 mg/kg and 50 
mg/kg body weight) without tumor implantation 
Weight (gram) % of increase p value 
Weight of Spleen 
PR-W-50 0.2848土0.037 181.6 <0.001 — 
PR-W-5 0.1582土0.027 56.38 <0.001 — 
Data was analyzed by student's r-test and p<0.05 was considered to be significant. 
The increase in the number of spleen cells was an indicator for enhancement of 
mitogenic activities, as it should be noted that mice are different from human that 
hematopoiesis continues throughout the life in murine spleen while this function 
disappears in human spleen (Fredrickson and Harris, 2000). The maturation of 
lymphocytes were occurred in spleens in mice and provided information for 
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different lymphoid cell types stimulated by immunophenotyping. 
The mushroom sclerotial extract, PR-W, was responsible for increasing the 
peritoneal exudate cells and this was due to the effect of polysaccharides present to 
stimulate the host immune response by targeting the macrophages derived from 
peritoneal cavity (Tomoda et a l , 1993; Figueras et al., 1998). Macrophages were 
known to be the first defense line in preventing foreign invasion and neoplastic 
diseases (Kiho et al., 1987). The release of peritoneal macrophages by 
polysaccharides was due to the liberation of monocytes from bone marrow into 
peripheral blood, followed by the activation of adherence to endothelial cells 
(Roesler et a l , 1991). P-glucans from lentinan and grifolan had no proliferative 
effects of peritoneal macrophages in vitro by measuring their H2O2 production 
(Adachi et a l , 1993), but polysaccharides from Phellinus linteus enhanced the 
peritoneal macrophages production through by determining the augmentation of 
phagocytosis (Kim et al., 2004). 
Proliferation of CD4+ and CD8+ T-cell population may be one of the causes to 
the enlargement of spleen (Goldsby et al., 2000). CD3+ positive cells represented 
the T cells and two subsets of CD4+ and CD8+ were two common T lymphocytes 
important for tumoral and immune studies. Many studies reported the cytotoxic 
effects of CD8+ and non-cytotoxic CD4+ cell because they were lymphocytes 
responsible for releasing proinflammatory cytokines that recruit different effector 
cells, including macrophages, neutrophils, eosinophils, etc. (Fomi et a l , 1988). 
Therefore, different kinds of cytokines would be released when these effector cells 
were stimulated. It was more popular to study the central role of CD4+ cells that 
they were particularly required for modulating immunity by striking a balance 
111 
between Thl/Th2 subset. The Thl subset was mainly responsible for classic 
cell-mediated function, for example, activation of cytotoxic T lymphocytes, while 
the Th2 subset was more responsible for activation of B cells. All these actions led 
to a further activation of T cells (Goldsby et al., 2000). However, neither the 
percentage of CD4+ or CD8+ cells treated by PR-W increased significantly when 
compared with the control (data not shown), so the significant increase of splenic 
weight induced by PR-W may be due to other pathways. This may be due to the 
reason that the splenocytes isolated only had a low percentage of cells being stained 
as the CD3+ cells, as a result, the CD3+/CD4+ cells and CD3+/CD8+ cells present in 
splenocytes were also low and the alteration of their level induced by PR-W when 
compared with that of control was not significantly observed. Over 95% of 
peripheral T cells (Goldsby et al., 2000) were CD3+ and there were only 25% of 
them in murine splenocytes (Li et a l , 1999). On the other hand, high percentage of 
B cells was also found in splenocytes and cell surface markers should also be tested 
for to see if B lymphocytes (e.g. CD45R/B220) were also induced since the 
peripheral blood cytokine profile showed that Th2 subset was activated and B cell 
activation in murine spleen was suspected to have occur (Hardy et a l , 1991). 
Therefore, cells other than these might be stained using other markers. 
Similar to the case in splenocyte, both control and cells treated with PR-W 
were stained at a low percentage with Mac-3 and NK 1.1 (data not shown). Mac-3 
was used as a marker for determining the presence of murine macrophages as it was 
used to recognize the mouse macrophage differentiation antigen, so, this marker was 
adopted as a general marker for macrophages that could be distinguished from 
lymphocytes (Ho and Springer, 1983). The level of Mac-3 and Mac-1 was found 
to be unchanged after the macrophage being activated by LPS (Bematchez et al., 
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1997). Therefore, other markers might be more suitable to use as alternatives for 
staining peritoneal macrophages in this case, for example, Mac-1 and ICAM-1. 
This was because these cell surface markers were specific for different stages or 
types of macrophages. Mac-1 was a cell surface marker specifically for mature 
macrophages (Leenen et al., 1994) and it was also a member of integrin superfamily 
of adhesion molecules (Bock, 1991). There was a mouse homologue of human 
intracellular adhesion molecule-1 (ICAM-1) (Prieto et al , 1989), and it was a ligand 
for Mac-1 which was partly responsible for lymphocyte, monocyte and neutrophil 
adhesion to endothelial cells that played an important role in adhesive functions in 
the immune system (Diamond et a l , 1991; Springer, 1990). 
Natural killer, NK cells were a kind of lymphocytes that recognized and killed 
target cells without prior sensitization and without the requirement for MHC 
restriction (Moretta et a l , 2002). It mainly functioned as preventing autoimmune 
killing of normal cells by expressing inhibitory receptors (Borrego et al., 2002; 
Natarajan et al., 2002). It also involved in the production of a wide range of 
cytokines such as IFN-y of Thl and IL-13 of Th2 (Bendelac et al., 1997; Godfrey et 
a l , 2000). NK 1.1 was a common cell surface marker for natural killer cells; 
however, it was usually used with other markers related to T lymphocytes for 
co-staining. Since the peritoneal exudate cells in this project was only stained with 
NK 1.1 alone without co-staining with other markers, the NK cells were not well 
selected for staining. It would be better to stain the NK cells with anti-TCRy/S and 
anti-TCRa/p in addition to and-NK 1.1 so that natural killer T cells were identified 
that co-express T-cell receptor and NK cell marker could be identified. 
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3.11 Correlation between antitumor activity and structure of mushroom 
sclerotial extract from hot water extraction alone 
The physico-chemical characteristics of mushroom sclerotial extract from hot 
water extraction alone were firstly determined by several analyses so that their total 
sugar, acidic sugar, protein contents, monosaccharide profile, linkages and molecular 
weights were obtained (Sections 3.2-3.4). Based on these information, the major 
component of PC-W was proposed to be consisted of glucans, while PT-W and 
PR-W had the structure of polysaccharide-protein complexes. 
PC-W had 90% glucose in its monosaccharide profile and the polysaccharide 
present was most likely to be a linear p-(l-^3)-glucan as indicated by GC-MS (data 
not shown). When compared with pachyman that had a highly branched p-(l-> 
3)-glucan structure (Chihara et al., 1970a), PC-W resembled a debranched 
pachyman (pachymaran) that has strong antitumor activities. Although both PC-W 
and pachymaran had similar structures, the methods of obtaining these two 
polysaccharides were different and it was reasonable to suggest that they had 
different biological activities. PC-W did not have an antitumor effect as good as 
that of pachymaran reported previously (Chihara et al., 1970a) since antitumor 
activity of glucans depend on several factors. It was known that the linear P-(l— 
3)-glucan in pachymaran was responsible for improved antitumor activities 
(Kanayama et al., 1983; 1986) and debranched lentinan had a more pronounced in 
vivo antitumor effect than native fractions against Sarcoma 180 at a dose of 2.0 
mg/kg (Sasaki and Takasuka, 1976). However, most of the mushroom 
polysaccharides that are biological active possess the structure of 3) glucan 
linkages as backbone with p-(l—6) linkages as branches (Franz, 1989). The 
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polysaccharide with only p-(l->6) linkages alone as backbone had very little 
antitumor activities (Jong et al., 1991). 
It was also important for p-glucans to have a linear structure in general and 
linked with a low ratio of branches in order to have pronounced antitumor effects 
(Ooi and Liu, 2000). This has been demonstrated in many known mushroom 
polysaccharides which all have potent antitumor activities with the presence of 
suitable branching ratio on a linear glucan chain (Ooi and Liu, 2000). Lentinan, an 
extract from Lentinus edodes, was a P-(l—3) glucan with two branches of (3-(l->6) 
as side chains in every five glucopyranosyl residues (Chihara, 1992) and was 
well-known to be effective against various kinds of both murine and human tumors 
(Komatsu et a l , 1969). On the other hand, Schizophyllan, isolated from 
Schizophyllum commune, was another extract that had the structure of 3) 
glucan. The branching ratio of schizophyllan was different from that of lentinan 
where there was one (3-(l—6) branch linked to every three glucopyranosyl residues 
(Tabata et a l , 1981). Although both schizophyllan and lentinan had similar 
molecular weight and conformation, different antitumor activities were found 
because their branching configuration was different (Ooi and Liu, 2000). 
Therefore, if suitable branching ratio was introduced to PC-W, its antitumor 
activities might be improved by promoting the performance of both in vitro and in 
vivo assays. 
Both PT-W and PR-W had a relatively high protein content so that they were 
suspected to have the structure of polysaccharide-protein complexes. As 
mentioned before, this kind of complex could be a protein-bound p-glucan (PSK) or 
glycan-protein complexes (PSPC). PSK refers specifically to 
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polysaccharide-protein complex extracted from Coriolus versicolor while PSPC 
referred to a wide range of compounds formed with polysaccharides and proteins. 
The major constituent of PSK was found to be p-glucan, however, PT-W and PR-W 
had a major composition of protein (about 40-60%) although the polysaccharide 
moiety consisted mainly of glucose (80%). PT-W contained 34.89% carbohydrate 
with glucose as the major monosaccharide, and other sugars like ribose, xylose, 
mannose and galactose were also present. PR-W had 37.42% of carbohydrate, also 
with glucose as the major monosaccharide and there were other sugars like 
rhamnose, ribose, mannose and galactose. These two hot water extracts were 
proposed to have a heteroglucan-protein structure. 
Many kinds of PSPC isolated from mushroom had potent antitumor activities. 
Polysaccharide-protein complex extracted from Tricholoma lobayense consists of 
54.3% polysaccharide with galactose, glucose, arabinose, xylose, rhamnose, fucose 
and mannose, and 35.9% protein (Liu et a l , 1995; Liu et al., 1996a). It was 
effective in inhibiting the growth of SI80 in both ICR and BALB/c mice without 
any in vivo toxicity (Liu et al., 1995; Liu et a l , 1996b). On the other hand, there 
were seven polysaccharide-protein complexes isolated from Ganoderma tsugae in 
which two of them were identified as protein-containing glucogalactans associated 
with mannose and fiicose, while the other five were protein-containing P-(l—3) 
glucans (Reshetnikov et al., 2001). The presence of heteropolysaccharides seemed 
to be critical for the antitumor activity as the activities were also strong as 
homoglucans when heteropolysaccharides consisted of galactose, glucose, mannose 
and fucose (Mizuno, 1995a; Zhuang et al., 1994). 
In general, mushroom hot water extracts with strong antitumor activities were 
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common that they usually consisted of proteins and more mannose, for example, 
mannan peptide from Lentinus edodes (Mizuno, 1999)’ glucomannan protein 
complex (ATOM) and mannan protein complex (AB-FP) from Agaricus hlazei (Ito 
et al., 1997), as compared with other kinds of extracts (glucose was present at 
>90%). In this project, extracts with more mannose exhibited higher antitumor 
activities. The two components found in PT-W had a molecular weight between 
103 X 103 and 295 x 10^ (Fig. 3.5) while those from PR-W had molecular weight of 
1.4 X 103 and 456 x 10^ (Fig. 3.7). The relatively small molecular weight fractions 
from two these hot water extracts had higher UV absorption, indicating higher 
protein content was present in these fractions. Since mannose was the second most 
abundant monosaccharide after glucose and it usually associated with proteins to 
form mannoprotein, it was reasonable to speculate that this small molecular weight 
fraction consisted mainly of mannoprotein complex while the fraction with higher 
molecular weight consisted mainly of glucan-protein complex. The relative 
proportion of low molecular weight fraction was higher (four-fold) than that of high 
molecular weight fraction in PT-W (Table. 3.6) while a comparatively closer 
proportion of low and high MW fractions was found in PR-W. It was mentioned 
before that a larger molecular weight would induce a higher antitumor activity and 
the minimum molecular weight required for effective antitumor activity was about 
lOkD (Adachi et al., 1990a). The situation in explaining the difference in 
antitumor activities of PT-W and PR-W became more complicated because other 
parameters, including their monosaccharide composition, protein moiety content and 
molecular weight variation would have great influence on their antitumor activities 
(Ooi and Liu, 2000). 
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Chapter 4. Conclusions and Future works 
A novel mushroom sclerotium, Polyporus rhinocerus (PR) was found to have a 
more potent in vitro and in vivo antitumor activities than two other known 
mushroom sclerotia, Poria cocos (PC) and Pleurotus tuber-regium (PT), previously 
studied (Chihara, 1970a; Zhang et al., 2001; Zhang et al., 2004c). 
The antitumor activities of sclerotial extracts obtained by different extraction 
methods were found to be different from those previously reported for PT and PC 
(Zhang et a l , 2004c). Extraction methods affect the structure-activity relationship 
of the mushroom sclerotial polysaccharides in these extracts, explaining the 
variations in the bioactivity. 
Among the various fractions of PR which had both direct cytotoxic and 
immunopotentiating effects, its hot water extract (PR-W), a polysaccharide-protein 
complex, was the most potent fraction. Further mechanistic studies by flow 
cytometry showed that PR-W caused a Gi arrest in HL-60 cells and stimulated the 
release of a wide range of cytokines, including IL-5, IL-12p70, IL-13 and 
chemokines such as GCSF and RANTES. In addition, weight of spleen, number of 
splenocytes and peritoneal exudate cells were found to be increased after the 
intraperitoneal injection of PR-W into non-tumor bearing BALB/c mice. This 
further suggested the immunostimulating effect of PR-W. 
Much more experimental work can be done in the future. Hot water extracts of 
mushroom sclerotia, particularly PR-W, were found to be effective against various 
cells in vitro and in vivo, but the detailed structures of the polysaccharide-protein 
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complexes in this extract which are important in explaining the potent antitumor 
activity of PR has not been reported as compared with that of PT and PC. In 
particular, the linkage of glucan in PR-W needs to be investigated as it is necessary 
to see if PR-W possesses the typical p-(l—3)-glucan or other different glucan 
linkages as backbone and different kinds of branches that lead to such a high 
antitumor activity. Furthermore, due to a high percentage of protein amount in 
both PT-W and PR-W, it is essential to study the protein moiety in order to 
distinguish how a different antitumor activity conferred by these two sclerotial 
extracts can be explained by different amino acids and protein structure. To further 
investigate the effect of PRW, fractionation of this crude extract could be performed 
to see whether the protein residues are bound to the polysaccharides in order to 
contribute to such a potent antitumor activity. It is noteworthy to study the activity 
of the sonication fraction of Pr because it had not only a high potent activity but also 
with a very high yield that allows large-scale production more feasible. 
Although hot water extracts of the three mushroom sclerotia showed cytotoxicity 
on various cell lines, the detailed mechanisms was still not clearly understood. The 
mode of an indirect cytotoxicity of the sclerotial extracts on these cells can be 
flirther studied by adding effector cells, for example, macrophages, to incubate with 
the extracts, so that the resulting medium after incubation can be isolated. This 
kind of medium can simulate an ex vivo environment to see how the hot water 
extracts modulate the host immunity to fight against the tumor cells. 
It was obvious that there was a Gi arrest of HL-60 cells by PR-W, however, 
various kinds of proteins and genes are involved in the Gi arrest that induce 
apoptosis. Western immunoblotting can be carried out to study the mechanism of 
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how PR-W affects the cell cycle through signal transduction by proteins that finally 
leads to apoptosis. 
Apart from the intraperitoneal way of administrating PR-W to mice, it is 
reasonable to test for other ways of administration, for example, per oral (p.o.) since 
the antitumor activities of PR-W might change due to the digestion of the protein 
moiety of the polysaccharide-protein complexes in alimentary tracts of the host. 
By doing so, the most effective route of administration to maximize the antitumor 
effect of PR-W can be identified. 
Only the immunostimulatory effects of PR-W in animal without a tumor burden 
were studied. It is known that PSK can only be effective in restoring immune 
response on host with tumor burden but not on normal host, while PSPC seems to be 
effective in both cases. In this way, whether the actions of PR-W are similar to 
PSK or PSPC can further be verified by comparing immunomodulating effects on 
mice with or without tumors. In addition, the pattern of cytokine expression in 
serum isolated from host with or without tumors may vary so that how the release of 
cytokines in tumor challenged animal model can be studied. In this project, 
cytokines expression from peripheral blood was measured instead of those from 
splenocytes and peritoneal exudate cells. However, this should be evaluated as 
well in order to enable a mechanistic study of how PR-W act on these cells to 
stimulate all other effector cells to potentiate the immune response. 
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